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Abstract 
The Endoplasmic Reticulum (ER) is the site of folding and assembly of 
secretory proteins. Fidelity of protein-based intracellular communication 
is guaranteed by protein quality control mechanisms located at the Early 
~ecretory Compartment (ESC), which restricts forward transport to native 
proteins. ERp44 plays a key role in the Ihiol-Mediated Retention (TMR) of 
variety of client proteins (Erol, SUMFl, Adiponectin, IgM) thus regulating 
their transport and localization. Little is known about the molecular 
mechanisms of ERp44-TMR and how it is regulated in living cells. Hence, 
the overall aim of this work is to investigate the structure-function 
relationship of ERp44. 
In collaboration with Wang's group the crystal structure of ERp44 was 
determined. The structure of ERp44 most likely represents a non-reactive 
conformation of the protein. Indeed, Cys29 is shielded from the bulk 
solvent by C-terminal tail and almost inaccessible for the formation of 
intermolecular disulfide bonds with client proteins. 
Based on the obtained structural data and functional studies, a panel of 
mutants of ERp44 has been characterized in order to understand how C-
terminal tail rearrangements expose substrate binding site, thus 
modulating substrates binding/ release in view of its role in TMR. 
Moreover, the pH gradient between ESC organelles was investigated as 
major determinant of C-terminal tail rearrangements. Given the known pH 
differences in the ESC, the data support the hypothesis of a role of the pH 
variation in governing ERp44-TMR activity in vivo. 
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A deeper knowledge of the structure/function relationship of ERp44 will 
shed light on the protein quality control mechanisms thus providing 
essential knowledge of ESC processing diseases and in biotechnology, 
improving the production of man-made therapeutic proteins. 
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1. Introduction 
1.1 The secretory pathway 
All cells secrete a number of molecules to modify their environment In 
order to protect themselves (or the organism they belong to), to interact 
with and "communicate" to one another. Smaller molecules are usually 
transported across the plasma membrane by carriers located in the 
membrane, whereas almost all secretory proteins in eukaryotes are 
secreted by exocytosis. In prokaryotes, secretion of proteins is directly 
mediated by the plasma membrane via either signal-recognition-particle-
dependent translocation which is homologous to protein translocation into 
the Endoplasmic Reticulum (ER) in eUkaryotic cells (Wolin 1994) or the 
prokaryote-specific Sec system (Schekman 1994). In contrast, eukaryotic 
cells have evolved a complex secretory pathway, consisting of several 
compartments which contain different sets of proteins (ER, Golgi complex, 
endosomes called endomembrane system) (Becker & Melkonian 1996) (Fig. 
1.1). Upon insertion into the ER, proteins travel through this 
endomembrane system to reach subsequent compartments and then their 
final destination. The secretory pathway (anterograde pathway) is 
countered by an endocytotic pathway (retrograde pathway) originating at 
the plasma membrane. The two pathways are interconnected by 
crossroads at various steps. Eukaryotic cells, thus, have evolved an 
integrated intracellular traffic system where vesicular shuttles are believed 
to be the major transport vehicles. 
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1. 1.1 Early secretory compartment (ESC) 
1.1.1.1 Endoplasmic reticulum 
ER consists of a network of membranous tubules and sacs called 
cisternae, so extensive that it accounts for more than half the total 
membrane in many eukaryotic cells. There are two specific regions of ER 
that are different in structure and function: rough ER (rER) and smooth 
ER (sER). The former is specialized in protein synthesis while sER has a 
central role in calcium storage/homeostasis and in the biosynthesis of 
steroids, cholesterol and other lipids. 
Th ER, the "gateway" of the secretory pathway, is the site of maturation 
of secretory proteins. Indeed, through its oxidizing environment and its 
specialized folding helpers, the ER provides an optimal milieu for protein 
folding and assembly. In the ER, several co-translational and post-
translational modifications take place that do not occur in the cytosol 
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such as disulfide-bond formation, N-linked glycosylation and GPI-anchor 
addition (see 1.2). These covalent changes are important for correct 
protein folding and assembly (Ellgaard & Helenius 2003). ER resident 
soluble proteins constitute a special class of proteins that can exit from 
ER, but eventually are retrieved back by specific receptor. Pelham and co-
workers (Munro and Pelham 1987) identified a C-terminal tetrapeptide 
motif (KDEL motif in mammals, HDEL in yeast) shared by several ER 
chaperones, including glucose-regulated protein-78 (GRP78), glucose-
regulated protein-94 (GRP94) and protein disulphide isomerase (PDI). The 
KDEL receptor (KDEL-R) is a seven-transmembrane-domain protein that 
awaits its ligands in the Golgi complex where, once bound the chaperone, 
sequesters it into vesicle to retrotransport chaperones to the endoplasmic 
reticulum. 
The proof of concept of this process was provided with the addition of the 
last six amino-acid residues of GRP78 to the C-terminus of an exogenous 
protein (lysozyme) engineered to be luminal and to cross the secretory 
pathway; this prevented its secretion, with its consequent accumulation in 
the ER (Munro and Pelham 1987). Indeed, over-expression of an HDEL-
tagged exogenous protein leads to increased secretion of the endogenous 
yeast chaperone GRP78, indicating that the HDEL retention system can be 
saturated by HDEL ligands and that chaperone retrieval into the ER is 
mediated by a specific receptor (Dean & Pelham 1990). Very recently, 
Sallese and co-workers (Pulvirenti et al., 2008) have reported that KDEL-R 
triggers a signalling cascade (see ESC signalling pathway 1.5). 
1.1.1.2 ERGIC 
The ER-Golgi intermediate compartment (ERGIC) is a complex membrane 
system between the ER and the Golgi complex. Although it is now 
generally accepted that the ERGIC is an obligatory intermediate 
compartment in protein transport from the ER to the Golgi complex, the 
question of whether the ERGIC is only a transient membrane structure 
(the maturation hypothesis) or a true compartment (the stable 
compartment hypothesis) remains unanswered (Appenzeller-Herzog & 
Hauri 2006). According to the maturation hypothesis, the ERGIC clusters 
would be formed by homotypic fusion of ER-derived, initially COPII coated 
vesicles, to form a new cis-Golgi cisternae (Bonfanti et aI., 1998) (Glick & 
Nakano 2009). This hypothesis is based mainly on studies at the light 
microscope level of the anterograde reporter GFP-tagged VSV-G protein in 
living cells (Presley et aI., 1997) (Scales et aI., 1997). The results of these 
studies however also support the stable compartment hypothesis, 
assuming the ERGIC clusters are highly dynamic. According to the stable 
compartment hypothesis, the ER-derived vesicles would fuse with ERGIC 
clusters rather than with themselves. Anterograde and retrograde traffic 
from the ERGIC would not entirely consume the clusters, but part of them 
would remain and function as an acceptor for new membrane traffic from 
both the ER and the cisGolgi. 
On the whole, in the most popular current view, major role of the ERGIC 
is the sorting of anterograde and retrograde traffic (Klumperman et al. 
1998) (8annykh et al., 1998) (Otte & Barlowe 2004) (Appenzeller-Herzog & 
Hauri 2006) (Glick & Nakano 2009). 
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1.1.1.3 Golgi complex 
In mammalian cells, Golgi Complex (GC) consists of flattened membrane-
bound compartments, called cisternae, which form Golgi stacks, 
themselves interconnected by lateral tubules to form the Golgi ribbon. 
Both Golgi stacks and ribbon are polarised with an entry (cis) face, where 
cargo molecules synthesised in the ER reach the Golgi complex, and an 
exit (trans) face, where they leave for downstream localizations (Pelham & 
Rothman 2000). 
The GC is situated at the "heart" of the secretory pathway, and its main 
functions are to modify (mainly through glycosylation) and sort proteins. 
Glycan addition can be again subdivided into two main groups: N- and 0-
glycosylation. The former is the addition of sugars to the amide nitrogen of 
asparagine side chains, while the latter to the hydroxyl groups of serines 
or threonines. N-glycosylation of proteins starts at the cytosolic face of the 
ER by the synthesis of a GlcNAc and mannose (Man) containing glycan 
chain onto the lipid dolichol phosphate. This chain is then flipped into the 
lumen of the ER, where it undergoes a further addiction of Man and 
glucose (Glue) residues. Eventually, oligosaccharyltransferase moves 
GlcNAc2Man9Gluc3 moieties onto suitable asparagine side chains of 
proteins co-translationally (see also 1.2). Elaboration of these glycan 
chains is performed in the GC to create an array of different structures 
classified into three categories. High mannose type chains end in mannose 
residues just like the ER exported form, and are similar to those prevalent 
in lower eukaryotes such as yeast. These mainly exist on a few specialized 
mammalian proteins. In contrast, to generate complex type N-glycans 
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most of the ER derived mannose residues are trimmed in the early Golgi. 
Addition of GlcNAc residues then generates further branches on the chain. 
To this galactose (Gal), sialic acid (NeuAc) and/or fucose (Fuc) are added 
in the late Golgi to create the final complex glycan product. The exact 
mechanism of O-glycosylation is less well established. The main forms of 
Golgi-derived O-glycans on higher eukaryotic secretory proteins are mucin 
type glycans and proteoglycans. 
Many glycosylation enzymes are expressed cell type specifically, restricting 
the choice to a subset of glycosyltransferase reactions in any given cell 
(Ungar 2009). Glycosyltransferases and glycosidases are sub 
compartmentalized; different cisternae of the Golgi complex contain a 
different set of enzymes (Ungar 2009). This allows enzymatic reactions to 
be operated sequentially, thus secretory proteins move along the Golgi 
complex like on a conveyor belt while reaching their final form. 
The endoplasmic reticulum, ERGIC and cisGolgi complex, called 
collectively Early Secretory Compartment (ESC)(Fig.l.l), have a stringent 
quality-control system for "proof-reading" newly synthesized proteins, so 
that only native conformers can leave the ESC reaching their final 
destinations (Anelli & Sitia 2008). Non-native conformers and incompletely 
assembled oligomers are retained, and, if misfolded persistently, they are 
degraded (Ellgaard & Helenius 2003) (Braakman & Sitia 2003). The ESC 
support the folding, assembly, post-translational modification and quality 
control as well just like a molecular "protein factory". 
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1.2 ESC protein/olding crew 
Protein folding of a newly synthesized protein can start as soon as the N-
terminus of the nascent peptide emerges from the translocon Sec61. A 
protein may be able to reach its native conformation without assistance, 
but this is unlikely in the crowded environment of the cell where the risk 
of aggregation is high . Therefore, a "folding crew" is present to take care of 
newly synthesized proteins (Dobson 2003) (Fig. 1.2). 
Adap ed from Dobson 2003 
Figure 1.2. Regulation of protein folding in the ER. 
Secretory proteins are translocated into the ER, where they gain their 
native structure with the help of ESC folding crew. Properly folded 
proteins are then transported forward. Non-properly folded proteins are 
d t cted by a quality-control mechanism and degraded by cytosolic 
prot asomes. 
Thi cr w can c talyze slow folding steps, prevent unproductive 
interactions with oth r prot ins, or prev nt proteins from getting trapped 
in o[[-p thw interm diat . A g n ral dang r during protein folding, 
wh th r in the cyto 01, ESC or mitochondria, is the exposure of 
h drophobi r sidu ,which may form und irabl intra-chain or inter-
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chain interactions, leading to misfolding and often aggregation. Hsp70 (-
like) chaperones present in all cellular compartments help to prevent this, 
keeping newly synthesized proteins in a folding competent state (Bukau et 
al., 2006). Protein folding in the ER involves two additional features that 
distinguish the process from folding in the cytosol, namely the formation 
of disulfide bonds, and attachment of N-linked glycans to polypeptides. 
Specialized chaperones and folding enzymes are involved in these 
processes (see also 1.2.2 and 1.2.3). 
Proteins that have not folded correctly interact with ESC-resident folding 
factors until they reach their native conformation. If the folding process 
fails, they eventually are released from the folding factors to be 
retrotranslocated to the cytosol, where they are degraded by proteasomes 
(Fig. 1.2). When a client protein has folded correctly, it is transported out 
of the ER towards its final destination. One-third ?f all proteins expressed 
in Saccharomyces cerevisiae fold in the ER and, for humans, this 
percentage may be even higher (Lander et aI., 2001). The diverse repertoire 
of ESC-resident folding crew reflects this diversity of clients: multiple 
members have been identified for several families of chaperones and 
folding enzymes (Fig. 1. 11). 
1.2.1 The classical chaperones 
Classical chaperones are grouped in several subfamilies HSPs of 40, 60, 
70, 90, and 100 kDa in size. The ER possesses a member of the Hsp70 
family (glucose-regulated protein (GRP)78/BiP (Haas IG and Wabl M.1983, 
(Brewer & Hendershot 2005), a chaperone of the hsp70 family that plays a 
key regulatory role in ER signalling UPR (see 1.4). BiP was first isolated as 
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a protein associating with unassembled Ig-H chains (Haas and Wabl, 
1983). Peptide binding studies have confirmed that SiP has a preference 
for peptides with aliphatic residues, which are usually buried in properly 
folded/ assembled proteins (Slond-Engluidi et al., 1993) (Foresti et al., 
2003). Like other Hsp70s, SiP has an N-terminal ATPase domain and a C-
terminal substrate binding domain. These domains communicate, as 
cycles of ATP hydrolysis and ADP-to-ATP exchange are coupled to cycles of 
substrate binding and. release (Mayer et al., 2003) (Christis et al., 2008) 
(Fig. 1.3). The interdomain linker is crucial in communicating substrate 
and nucleotide binding from one domain to the other, an event that is 
accompanied by major conformational changes in both domains (Jiang et 
al., 2005) (Awad et al., 2008). Owing to the weak SiP ATPase activity, 
Hsp40-like co-chaperones containing J domains (ERdj) play a key 
regulatory role. Five ERdj proteins have been isolated so far (Cunnea 
2002) (Kroczynska et al., 2005) (Shen & Hendershot 2005). One of them, 
ERdj5, also displays oxidoreductase activity, possibly linking SiP-
dependent folding/unfolding and disulfide bond formation, isomerisation 
or reduction (Ushioda et al., 2008). 
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/ 
From Christis et al., 2008 
Figure 1.3. The chaperone BiP ATPase cycle. 
The cycle starts by the binding of substrat , which may be presented by 
one of the five J proteins in the ER. J then stimulates BiP's ATPase 
activity and bound ATP is hydrolyzed, leading to a conformational change 
in BiP, which closes the lid domain and drastically decreases the on and 
off rates of substrate from BiP. One of the two nuCleotide exchange 
factors then mediates the release of ADP, allowing the binding of ATP, 
which opens the lid to release the substrate for another round. 
BiP levels are tightly controlled and are elevated upon physiological (e.g., 
c 11 differentiation increasing the ER load with cargo proteins) or 
pathological (accumulation of misfolded proteins) stress responses. 
During embryogenesis, BiP xpression r mains below detection limit to the 
morula stage, but becomes abundant at the blastocyst stage in E3.5 
mbryos (Kim taL, 1990). It is th r fore not surprising that the BiP-/-
mice cannot surviv b yond this stage, and the cells when cultured in vitro 
cannot pro liD rat and rapidly degen rate (Luo t al., 2006). A partial 
r duction in the 1 v 1 of BiP is tolerat d s BiP/- embryos and adult mice 
ar norm . Th ntial ro1 of BiP in c 11, tissue, and organism 
hmo is und r cor d by th id n tific tion of BiP a the cellular 
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target of one of the most potent bacterial toxins ever characterized the 
subtilase cytotoxin (SubAB). SubAS is produced by a highly virulent Shiga 
toxigenic Escherichia coli strain responsible for the 1998 outbreak of 
hemolytic uremic syndrome in Southern Australia. SubAB inactivates SiP 
through a single-site cleavage that disconnects the substrate binding from 
the ATPase domain of the molecular chaperone (Montecucco & Molinari 
2006). The disruption of BiP activity results in rapid cell death. 
1.2.2 The lectin chaperones 
The majority of secreted proteins are modified by multiple N-linked 
glycans. N-glycans play key roles: during folding they dictate the 
association with lectin chaperones, increase the solubility of the 
polypeptide. In contrast to BiP that binds directly to the hydrophobic 
backbone of the polypeptide, the lectin chaperones bind the glycans. Once 
the protein is folded, glycans participate in many key biological processes, 
such as selfuon-self recognition in immunity, signal transduction, and cell 
adhesion (Ohtsubo & Marth 2006). 
N-linked glycosylation of asparagine residues in an N-X-S'f motif is an 
ER-specific protein modification. Preformed oligosaccharide units 
(GlcNAc2-Man9-Glc3) are co-translationally transferred en bloc to the 
nascent protein by the oligosaccharyltransferase complex (Hebert & 
Molinari 2007) (Fig. 1.4). Indeed, as folding proceeds, glycan acceptor sites 
can become buried and remain unmodified. This suggests folding and 
glycosylation compete with each other in vivo (HoIst et al., 1996) (Foresti et 
al., 2003). 
Glucose trimming by glucosidases I and 11 produces a monoglucosylated 
species that can bind to the lectin chaperones calnexin and calreticulin 
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(Hammond & Helenius 1994). The two proteins are highly homologous, 
apart from the fact that calnexin is a transmembrane protein and 
calreticulin is soluble . Calnexin is thought to interact with glycans closer 
to the membrane, whereas calreticulin binds more peripheral glycans 
(Molinari 2007). Although both proteins could potentially associate with 
soluble and membrane proteins, they indeed, interact with a distinct set of 
client proteins. This may partly be the result of their different localization 
in the ER because, when the transmembrane segment of calnexin was 
fused to calreticulin, the pattern of associating proteins shifted towards 
that normally seen for calnexin (Molinari & Helenius 1999) (Molinari 
2007). 
3xGLUCOSES 
9xMANNOSES 
} 2X N· Acetyllgucosamine 
N-AsN-X-SerlThr-C 
Adapted from Hebert and Molinari 2007 
Figure 1.4. Structure of Nlinked oligosaccharides . 
Th high manno pr cur or coval ntly attached to Asn-X-SerjThr 
qu nc of n nt p lyp ptid ch'n normally contains 9 mannose 
r idu and 3 gluco .3 M nno (orang ircle) and 3 glucoses are 
furth r r mov d during proc ssing and quality control. e text for the 
d tails . 
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Upon substrate release from calnexin (Fig. 1.5, steps 2 and 2a), 
glucosidase II also removes the final glucose (glucose 3) creating the 
unglucosylated substrate, thus inhibiting substrate rebinding to the lectin 
chaperones (Fig. 1.5, step 3 for native proteins, step 3a for folding 
intermediates, and step 3b for folding-incompetent polypeptides). 
Regeneration of the monoglucosylated state and rebinding to the lectin 
chaperones IS controlled by the UDP-glucose: glycoprotein 
glycosyltransferase (GT; acronyms such as UGT or UGGT are also 
commonly used), and it is only possible for nearly native folding 
intermediates (Fig. 1.5, step 4a) (Caramelo et aI., 2003) (Caramelo et aI., 
2004). GT ignores native proteins that are released into the secretory 
pathway (Fig. 1.5, step 4) and extensively misfolded polypeptides that are 
prepared for dislocation into the cytosol and degradation (Fig. 1.5, step 
4b). GT is comprised of two main functional domains: a large NH2-terminal 
domain that binds non-native structures and a COOH-terminal 
carbohydrate transferase domain (Guerin & Parodi 2003). This protein 
transfers a single glucose onto non-glucosylated side chains of 
glycoproteins that contain non-native structures (Caramelo et aI., 2004) 
(Taylor et aI., 2004). Studies using purified proteins have demonstrated 
that GT recognizes glycans localized proximal to the misfolded domain 
(Ritter & Helenius 2000). However, another study found that GT could 
modify a glycan that was separated from the protein defect by at least 40 A 
(Taylor et aI., 2004). GT provides the essential connection that links the 
non-native exposed hydrophobic properties of a maturing protein to the 
composition of its exposed hydrophilic modification responsible for 
recruiting chaperones. Proteins do not cycle between UGGT and 
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calnexinlcalreticulin indefinitely, however, and those who fail to fold need 
to be removed from the ER (Hebert & Molinari 2007) (Fig. 1.5). 
Fro n Heber t an l olinari 2007 
Figure 1.5. The fate of newly synthesized glycoproteins in the ER 
lumen. See text for details. 
1.2.3 Oxidative f olding 
Th ER lumen contains varIOUS oxidoreductases assisting in disulfide 
bond formation in newly synthesized proteins. Disulfide bonds play a role 
in protein folding/ assembly, in the stabilization of secretory proteins and 
their folding interm diates (structural disulfide bonds) but, also in the 
r gulation of th function of certain proteins (functional disulfide bond) 
(Danon 2002) . 
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1.2 .3 .1 Protein disu lfide isomerase (PDI) 
PDI was the first folding catalyst ever reported (Venetianer and Straub 
1963) . It is an ER-located protein with a classic -KDEL ER retrieval motif. 
PDI is currently recognized as having four distinct domains, a, b, b', and 
a', plus a highly acidic C-terminal extension c and a 19-amino-acid long 
interdomain linker between the b' and a' domains named x (Tian et al., 
2006) (Fig. 1.6). 
b b' 
dapted from Tan et al . 2 6 
Figure 1.6. Primary structure of Yeas t PDI 
Domain organization of yeast PDI based on the crystal structure (c 
represents the C-terminal tail). The -CGHC- motifs indicate the location 
of the active sites, the C the non-active site cysteines, and X the loop 
connecting the b' and a' domains . 
The active sites of most PDI family members consist of a -CGHC- motif 
(Cys, Gly, His, Cys). When PDI is in the oxidized state, the disulfide can be 
transferred to the substrate to catalyze its oxidation, whereby the active 
site itself becomes reduced. When in the reduced state, substrate 
disulfides can be reduced and the active site ends up in the oxidized state 
(H b rt & Molinari 2007) (Fig. 1.7). These thiol-disulfide exchange 
r action proceed through the formation of a transient mixed disulfide 
betw n nzym and substrat . 
inc r duction r quir s th second cystein to resolve the mixed disulfide 
with th ubstrat, mutation of this r sidue leads to the accumulation of 
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covalent complexes through an intermolecular disulfide (Walker et al ., 
1996). 
The PDI also catalyze the rearrangement of incorrectly-formed disulfides in 
the process called isomerization (Fig. I. 7). Since non-native disulfides are 
often formed during folding and prevent the formation of the native 
structure (Jansens et aI., 2002), isomerization is a crucial reaction. 
oxidation .. 
• reduction 
H SH 
Adapted from Hebert and Molinari 2006 
Figure 1.7. PDI oxidation, reduction and isomerization of disulfide 
bonds. See text for details. 
In addition to its role in disulfide bond formation, PDI is the ~ subunit of 
prolyl-4-hydroxyla e (Koivu et al., 1987) and microsomal triglyceride 
trans£ r protein (Wetterau et al., 1991). PDI is also implicated in peptide 
loading onto MHC class I (Peaper & Cresswell 2008), and in regulating 
NAD(P)H oxidase (Janiszewski t al.,2005) in the ER. Recently, a number 
of r ports indicat d that PDI is, ind ed, a marker for the release of 
intr llular cont nts from damaged cells (for example, activating tissue 
f ctor VIa taly i of thiol-disulfid exchange and thus initiating the 
blood- 10 ting ca ad t th sit of wound damage) (Reinhardt et al. 
200 ). 
29 
The crystal structure of yeast POI (Tian et aI., 2006) revealed that the four 
thioredoxin domains are arranged in the shape of a 'twisted U', with the 
two active sites (in domain a and a'-) facing each other from a distance of 
28 A (Fig. 1.8). A highly hydrophobic patch in the b' domain together with 
hydrophobic areas surrounding the active sites, form a continuous 
hydrophobic surface across the a-, b'-, and a' domains (Tian et aI., 2006). 
Recently the same group describes an alternative conformation of the 
protein; the overall structure of yeast POI is no longer in the "twisted U" 
conformation described earlier, but instead adopts the shape of a "boat" 
(Fig. 1.8) with the b- and b' domains at the bottom and the a- and a' 
domains at the bow and stern. Compared to the "twisted U" structure, the 
active sites in a- and the a'- domains no longer face each other. The 
crystal structure also featured a POI dimer, and a propensity to dimerize 
in solution and in the ER was confirmed by cross-linking experiments and 
the split green fluorescent protein system (Tian et aI., 2008). In the dimer 
observed in the "boat" structure, both the active site in a' domain and the 
potential Substrate Binding Site (SBS) in the b' domain are buried. This 
conformation therefore presumably represents an "inactive" state of POI, 
because most of its catalytic elements are inaccessible (Tian et aI., 2008). 
On the other hand, the "twisted U" conformation most likely represents an 
"active" form of POI since its catalytic elements are exposed to the solvent. 
The transition between monomeric and dimeric POI could be a regulatory 
mechanism whereby the ER adjusts its folding capacity to meet different 
cellular demands. 
Another conformational change reported in POI (human POI- Nguyen et 
aI., 2008) is linked to substrate-binding site availability in domain b '. In 
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both yeast POI and human POI, the b' domain is thought to be a primary 
substrate binding site (Klappa et al., 1998) (Tian et al., 2006). Biophysical 
and NMR analysis indicated that the x region could move from a 
conformer in which it capped the SBS in domain b', to that observed in 
the crystal structure of yeast POI, in which the SBS was uncapped 
(Nguyen et al., 2008). Such change in conformation could be linked to the 
substrate-binding cycle and may also modulate the specificity of substrate 
binding by PO!. 
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'From Tian et at., 2006 
c 
a 
From Ti an et at. 2008 
Figure 1.8. Overall structures of yPDI. 
Ribbon diagram of PDI with the a, b, b', and a' domains in magenta, 
cyan, yellow, and red, respectively, and the C-terminal extension in 
green . The side chains of the active site cysteines in the a and a' 
domains are showed in spacefilling representation with the sulfur atoms 
in yellow. The top picture is "twisted U" structure (accession number 
2B5E) while b low is "boat" structure (accession number 3BOA). 
1.2.3.2 PDI Family 
Although PDI was for a long tim consider d as the sole enzymatic catalyst 
of thiol-disulfid exchang r actions in the ESC, it is now clear that other 
PDI homologu ar important in this process. Indeed, 19 other ESC-
r id nt prot in with t 1 st on thior doxin-like domain h a e been 
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identified so far In humans (Appenzeller-Herzog & Ellgaard 2008) (Fig. 
1.9). 
\ L" ·t u· 
:a .f), "-
d. . .! nO, 
~'---~·-----I::ffl---·- .-----.. -. 
From Appenzeller-Herzog & Ellgaard 2008 
Figure 1.9. Overview of the proteins of the Human PDI family 
The unifying feature In terms of sequence and structure IS the 
thioredoxin-like domains that can be either catalytic or non-catalytic. 
These two types of domains are called a- and b-type domains, respectively , 
and are distinguished based on sequence similarity. The a -type domains 
usually contain two cysteines in a CXXC active-site motif, with an 
intervening GH sequence being the most common in the PDls. The b-type 
domains do not have cysteines at the active site and are therefore not 
redox active. Most human PDls are soluble proteins with a C-terminal 
KDEL-like ER-localization motif. Four PDls are transmembrane proteins of 
the TMX (for "thioredoxin-related transmembrane protein") subgroup. 
TMX2 and TMX3 have typical C-terminal KKXX ER localization motifs. The 
family members differ from PDI in domain organization, tissue specificity 
and / or sequence of the active site (Hatahet et al. ,2009). The multitude of 
PDI family members reflects both the importance and difficulty of 
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introducing correct disulfide bonds into client proteins. All of the different 
family members may have their own expertise in assisting either specific 
clients or different stages in the folding process. Indeed, Winther and co-
workers (N0rgaard et aI., 2001) have showed that, in S. cerevisiae, the five 
POI homologs are not functionally interchangeable. In mammalian cells, 
the differences between POI family members are illustrated by the 
opposing roles played by POI and ERp72 in retro-translocation. Forster et 
al. (Forster et aI., 2006) found that POI facilitated retro-translocation of 
cholera toxin and misfolded protein substrates, whereas ERp72 mediated 
their retention in the ER. 
ERp57 (also known as ERp60, ERp61, GRP57, GRP58, HIP-70, and Q-2) 
is the closest homolog of PO I. 
It is very similar in length and domain architecture to POI, with the most 
striking difference being that the c region of POI is highly acidic, whereas 
ERp57 contains multiple lysine residues. As a result of its interaction with 
the two related, ER lectin chaperones CNX and CRT (Ellgaard & Frickel 
2003). ERp57 acts on glycosylated substrates (Oliver 1997) (Molinari & 
Helenius 1999). ERp57 is a multifunctional oxidoreductase that readily 
catalyzes dithiol oxidation, disulfide isomerization, and reduction in vitro 
(Frickel et aI., 2004) (Lappi et aI., 2004). ERp57 has been most widely 
studied for its role in the immune system because of its involvement in the 
assembly of the heavy chain of major histocompatability complex (MHC) 
class I molecules (Wearsch & Cresswell 2008) (Oong et aI., 2009). 
However, it also has a role in ESC quality control for other newly 
synthesized glycoproteins and has been implicated in the enzymatic 
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functions of phospholipase C, carnitine palmitoyl transferase, oxidase and 
reductase (Coe & Michalak 2010). By a combination of a cross-comparison 
with POI a binding site in the b' domain of ERpS7 was identified as the 
lectin P-domain interaction site (Russell et aI., 2004). This result implied 
that the b' domains of PDI and ERp57 have become specialized in function 
relating to direct and indirect substrate recognition. 
1.2.3.3 Endoplasmic reticulum oxidoreductin 1 (Ero1) 
The active site of POI needs to be recharged after oxidizing a client protein. 
A long-standing debate on how this is accomplished was terminated by 
the identification of Ero 1 p (ER oxidoreductin IS a glycosylated 
flavoenzyme) in a screen for yeast mutants defective in disulfide bond 
formation (Frand & Kaiser 1998) (Pollard et aI., 1998). 
The characteristic elements of both yeast and mammalian Ero 1 proteins 
are the bound flavin cofactor FAO, a catalytic CXXCXXC motif and a 
thioredoxin-like dicysteine motif. 
Ero 1 and POI form the major pathway for protein disulfide bond formation 
in the eukaryotic ER (Masciarelli & Sitia 2008) (Fig. 1.10). Ero 1 influences 
protein oxidation by coupling the oxidizing power of molecular oxygen and 
its flavin cofactor to generate disulfide bonds (Tu & Weissman 2004) 
(Gross et aI., 2006). These disulfides are transferred from Ero1 to the 
soluble disulfide-carrier PDI, which directly transfers its disulfides to 
folding secretory proteins (Frand & Kaiser 1999) (Sitia et aI., 2000) (Sitia 
et aI., 2001). Transfer of electrons from substrate proteins to POI and from 
PDI to Ero 1, proceeds as a series of direct thiol-disulfide exchange 
reactions (Sevier & Kaiser 2008). Recently, Wang and co-workers 
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reconstituted in vitro reconstitution of the Ero 1-PDI -substrate oxidation 
system (Wang et aI., 2009) . 
dapted from asci.arell i and Si tia 2008 
Figure 1.10. Ero oxidative folding. 
In eUkaryotic cells, oxidative folding of cargo p roteins is based on serial 
disulfide interchange reactions involving PDI and Ero 1 molecules . In 
vitro, yeast Ero 1 is oxidized by m olecular oxygen generating H20 2 in 
stoichiometric amounts to the d isulphide onds formed. 
This pathway is fundamentally conserved in higher eukaryotes, although 
some important d ifferences exist between yeast and mammalian cells. 
First, whilst a s ingle Ero 1 gene exists in Saccharomyces cerevisiae, two 
isoforrns, Ero1a and Ero1(3, are found in mammals . Both are able to 
complement yeast Ero1 defective mutants, underscoring the conservation 
of the oxidative folding pathways. Ero1a is induced by hypoxia (Gess et al. 
2003) and PPARy and inhibited by SIRT1 (Qiang et al., 2007) . In contrast, 
Ero 1 ~ incr ases during the UPR (Pagani et al., 2000), and is constitutively 
xpr ss d at high levels in certain secretory tissues (Dias-Gunasekara et 
al., 2005), on firming that ER stress responses are important for the 
acquisition of th secretory phenotype (Brewer & Hendershot 2005) 
(M asci r lli & itia 2008). The r asons underlying the functional 
diff r nti tion b tw n Ero1a and Ero1~ in mammals ar not yet clear. 
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Another remarkable difference between yeast and mammalian Ero 1 
molecules concerns the mechanisms of sub-cellular localisation. A C-
terminal tail is present in yeast Ero 1 p that mediates membrane 
association and IS essential for function. Neither Ero la nor Ero 113 
possesses this tail. Both are secreted by mammalian cells when over-
expressed, implying saturable retention mechanism(s). It was 
demonstrated that the localisation of Ero 1 a and Ero 113 depends on 
dynamic interactions with PDI or ERp44 (Otsu et aI., 2006), two soluble 
proteins that despite the presence of ER localisation motifs (KDEL and 
RDEL, respectively) are differentially distributed in the early secretory 
pathway (Masciarelli and Sitia 2008). 
1.3 ESC Quality control 
In the late 1980s, work on oligomeric viral proteins (Kreis and Lodish, 
1986)(Gething and Sambrook, 1989), the T-cell receptor (Bonifacino et aI., 
1989)(Sanchoet et aI., 1989) and immunoglobulins (Bole et aI., 1986)(Sitia 
et aI., 1987) (Hendershot and Kearney, 1988) revealed that proper folding 
and assembly are requisites for transport to the Golgi complex and 
onwards along the secretory route. Klausner referred to this phenomenon 
as 'Architectural editing'. The term 'ER Quality Control' (ER QC) (Hurtley 
and Helenius 1989) eventually has been proposed to indicate the 
processes of conformation-dependent molecular sorting of secretory 
proteins. The aberrant proteins are eventually retro-translocated (or 
dislocated) across the ER membrane for degradation by cytosolic 
proteasomes (ERAD). The identity of the retro-translocation 
channel(s)/dislocon(s) remains controversial as a number of ER 
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membrane proteins have been proposed to serve this function for the 
ERAD pathway including Sec61, Derlin and E3 ubiquitin ligase family 
members (Nakatsukasa & Brodsky 2008). The term "ESC quality control" 
has been becoming effective since emerging evidence indicated that also 
ERGIC and cisGolgi are involved in protein quality control (Anelli et al. 
2007) (Anelli & Sitia 2008). 
ESC protein QC is intimately linked to the processes of folding/ assembly 
(Ellgaard and Helenius, 2003) (Sitia and Braakman 2003) (Fig. 1.11). Both 
rely on chaperones and devoted resident enzymes. QC serves different 
roles (Anelli and Sitia 2008): 
(i) It prevents the deployment of aberrant protein conformers, ensuring 
that only native proteins proceed along the secretory pathway; 
(ii) it retains precursors in an environment suitable for their maturation; 
(iii) it increases their local concentration to favour assembly and 
polymerization; 
(iv) it reduces the risks of proteotoxicity by inhibiting aggregation and 
degrading terminally misfolded proteins; 
(v) it maintains homeostasis in the early secretory pathway; 
(vi) it is involved in the developmental regulation of protein secretion (IgM, 
adiponectin, see below) 
(vii) it is important for storing proteins for regulated secretion. In plants, 
in fact, ER retention/ accumulation is utilized to store abundant proteins 
during seed formation (Mainieri et aI., 2004) (Jolliffe et aI., 2005). 
A crucial part of the ESC quality control is therefore the recognition of 
terminally misfolded chains, their extraction from cycles of futile folding 
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attempts, their unfolding and transport into the cytosol for proteasome 
mediated degradation (Meusser et aI., 2005). 
Pro m.: I oc (r n IOn) 
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From n el li and S itia 2008 
Figure 1.11. ESC Quality control 
Molecular chaperones help secretory proteins to undergo their native 
structure. Certain proteins that are produced in large amounts, or are 
intrinsically difficult to fold, are assisted by specific (private) chaperones 
and enzymes. QC can occur in sequential steps. Indeed, after a proximal 
QC, certain subs trate s . (generally multimeric proteins) seem to undergo 
also distal QC checkpoints in ERGIC and eis-Golgi. This model could 
mediate cargo concentration and selective export of oligomerized species, 
thus coupling fidelity and efficiency in the secretory protein factory. 
While proximal QC can rely on simple retention, the distal checkpoints 
likely imply substrate retrieval to the ER, either for further attempts to 
fold, or for retro-translocation and degradation. 
Protein quality control system is coordinated by a number of molecular 
chaperones that monitor non-native determinant in the newly synthesized 
proteins such as: 
1. Presence of immature glycans; 
2. Exposure of hydrophobic patches; 
3. Exposure of reactive thiols (Thiol-mediated retention). 
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The finding that inhibition of mannose removal from N-glycans protects 
folding-defective polypeptides from ERAD led to the concept of the 
'mannose-timer' (Helenius, 1994). According to this model, removal of 
mannose residues from N-glycans terminates the maturation phase and 
initiates a series of events, still incompletely characterized, that eventually 
lead to retro-translocation of the terminally misfolded polypeptide into the 
cytosol (Fig. 1.5 and 1.11). In contrast, protection from de-mannosylation 
prolongs the lag phase that precedes the onset of degradation of the 
misfolded glycoprotein by retarding release of the substrate from the 
calnexin chaperone system (de Virgilio et aI., 1999) (Molinari et aI., 2002). 
Numerous studies with inhibitors in mammalian cells revealed the active 
involvement of kifunensine-sensitive 1,2- mannosidase(s) in ERAD 
regulation (Cabral et aI., 2001) (Helenius & Aebi 2004) (Hebert et aI., 
2005) (Lederkremer 2009). 
Removal of this mannose residue, the only acceptor for UGT-catalyzed 
protein re-glucosylation, thus seems to be a potent signal for glycoprotein 
disposal in mammalian cells because it results in the irreversible 
interruption of futile folding attempts 10 the calnexin cycle. Which 
protein(s) perform the extensive mannose trimming observed during 
preparation of the folding defective polypeptides for proteasomal disposal 
is still a matter of debate and extensive research. At least three 
possibilities exist: 
(1) co-sequestration of ERAD candidates and ER mannosidase I in 
specialized sub-regions of the ER (Frenkel et aI., 2003) in which the 
mannosidase concentration reaches levels similar to those showed in vitro 
to cause extensive mannose removal (Herscovics, et al., 2002) 
40 
(2) intervention of Golgi endo-mannosidase(s); 
(3) intervention of a new class of recently characterized mannosidase-like 
proteins, EDEM 1, EDEM2 and EDEM3 (Molinari et aI., 2003) (Oda et aI., 
2003) (Hirao et aI., 2006) (Mast & Moremen 2006). 
The recognition of non-glycosylated ERAD substrates has received less 
attention, but recently two studies have showed that, as non-glycoproteins 
are substrates of GRP94 or BiP, their ERAD pathways do not completely 
overlap with those for glycoproteins (Christianson et aI., 2008) (Okuda-
Shimizu & Hendershot 2007). BiP and PDI have been showed to be 
involved in ERAD by targeting a (3-secretase isoform for degradation 
(Molinari et aI., 2002)(. How and whether BiP and PDI can discriminate 
between folding intermediates and folding failures is unclear. 
Although changes in local structure can be sufficient to retain a protein in 
the ESC, retention is not always this strict. Mutations in the ligand 
binding domain of the LDL receptor that cause hypercholesterolemia 
because of impaired LDL binding do not prevent the protein from leaving 
the ER and travelling to the cell surface (Hobbs et aI., 1990). This is just 
one of many examples underscoring that quality control is based on 
structural and not functional criteria. 
Very rarely glycoproteins are found to bind simultaneously to BiP and 
CNX or CRT. Therefore, it seems that a given glycoprotein enters first 
either the BiP or the CNXjCRT pathway. The initial choice is dictated by 
the localization of the N-glycans: the closer these are to the N-terminus of 
the nascent protein, the higher the tendency to use CNX as a chaperone 
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system (Molinari 2000). If the first attempts to fold fail, the protein can 
shift to the alternative pathway. Altogether, these data imply that sites of 
conjunction exist in which the substrate can jump from one pathway to 
another. In principle, however, it should be possible for large multi-
domain proteins to engage with both. 
1.3.1 Thiol-mediated retention 
Studies of immunoglobulins (Ig) have revealed another mechanism of 
quality control, based on the recognition of exposed thiols on assembly 
intermediates (Ihiol-Mediated Retention-TMR; Alberini et al., 1990). In 
plasma cells, IgM secretion is restricted to examers (()..l2A.2)6) or pentamers 
(()..l2A.2)S-J), in which individual subunits are linked by disulphide bonds 
involving a conserved cysteine residue (CysS7S) in the IgM chain C-
terminal tailpiece ()..ltp) (Fig. 1.12). 
IgM monomer J.lA IgM polymer 
Figure 1.12. IgM structure. 
The building block of IgM, the "monomer" )..lA.. The )..l and A. chains are 
disulfide bonded with one another. The )..l tailpiece contains the CysS75 
that is involved in IgM polymer assembly in pentamer or hexamer. 
The first assembly step ()..l2A.2 formation) from individual J-l and A is fast and 
fficient in both B and plasma cells: its fidelity is mainly checked by BiP 
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(so called proximal/canonical QC, see Anelli and Sitia 2008) In the ER 
(Fig. 1. 13). 
In addition, after a proximal QC, IgM seem to undergo also distal QC 
checkpoints in ERGIC and cisGolgi complex. Indeed, IgM polymerization is 
slow and occurs downstream to ER. Here a pool of ESC resident proteins 
(ERp44 and ERGIC-53-Anelli et aI., 2007) support and check the 
oligomerization of unpolymerized IgM subunits that have already passed 
the BiP-dependent checkpoints (Anelli et aI., 2003). As a hexameric 
membrane-embedded lectin, ERGIC-53 may provide a platform for IgM 
polymerization (Anelli et aI., 2007). In the cisGolgi, ERp44 could capture 
unpolymerized IgM subunits and retrieve them via RDEL-dependent 
mechanisms. 
The delayed interactions of nascent /..I chain with ERp44 and ERGIC-53 
with respect to BiP in B-Iymphoma cells (Anelli et aI., 2007) support the 
existence of sequential steps in IgM polymerization. The sub-cellular 
localization and coordinated increase of ERGIC-53 and ERp44 during B-
cell differentiation suggest that the spatial subdivision within the early 
secretory compartment is important to promote IgM biogenesis (Reddy & 
Corley 1998)(Fig. 1.13-14). 
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Figure 1.13. Schematic model of the IgM polymerization 
machinery 
The IgM assembly occurs step-wise. The distribution of ERp44 in the 
early secretory pathway (primarily in the ERGIC) is depicted as a 
gradient of gray. BiP-dependent control ensures that )l chains do not 
proceed to the polymerization machinery unless assembled with A 
chains (first QC step). ERGIC-53, a hexameric lectin captures )l2A2 
subunits, likely aligning them in a planar conformation, suitable for 
polymerization. ERp44 ensures that unpolymerized subunits are not 
secreted, retrieving them into the assembly line (second QC step). 
Because of its ability to bind IgM subunits and ERGIC-53, ERp44 may 
recruit and locally concentrate )l2A2 , to stimulate further the 
polymerization machinery efficacy. 
Another example of sequential QC comes from adiponectin, a plasma 
protein secreted by adipocytes (Scherer et al., 1995) (Chandran et al., 
2003) . Plasma adiponectin is composed of trimers, hexamers and higher 
molecular weight oligomers (Bobbert et al., 2005)(Lara-castro et al., 2006) . 
ERp44 was show d to retain folded adiponectin trimers, forming mixed 
disulfides with Cys39 in one subunit (Qiang et al., 2007) (Wang et al., 
2007) . As in the case of IgM, therefore, folded adiponectin intermediates 
ar r tained by thiol-d pend nt m chanisms. 
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Adapted from Reddy and Corley 1998 
Figure 1.14. Schematic representation of the thiol-retention 
mechanism of IgM. 
The thiol retention mechanism is illustrated by the presence of the 
"lumen trolls" (ERp44) whose function is to monitor the oxidation status 
of the Cys575 "hook" on all assembly intermediates. Assembly proceeds in 
a step-wise fashion using the subunits from this pool by means of the 
Cys575 of the 1-1 heavy chains. Once the polymer has been covalently 
closed, Cys575 is masked and the quality control requirements of the 
ESC, therefore, allow the exit of the polymers. 
Whilst the ER localization of soluble resident proteins largely depends on -
KDEL receptor-mediated retrieval from the intermediate compartment or 
Golgi complex (Pelham and Munro, 1993)(Meunier et al., 2002), ER 
retention seems to be the fate of thiol-exposing proteins (Isidoro et aI., 
1996) (Anelli et al., 2003). 
Considering that PDI and ERp44 can bind to different cysteines in Ero la 
(Sertoli et al., 2004), the absence of ternary covalent complexes is 
surprising and may reflect temporal and/ or spatial regulation within the 
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ER. ERp44 retains cargo proteins with exposed thiols, probably acting as 
a "late check point" in quality control (Anelli et aI., 2003). The dynamic 
retention mode of Ero 1 by alternative interactions with PDI and ERp44 
could therefore provide multiple sites for disulfide bond formation that 
may correspond to the execution of sequential steps in the structural 
maturation of complex molecules. 
Likewise, formylglycine-generating enzyme (FOE) (Mariappan et aI., 2008) 
localizes in the ER despite it lacks of KDEL motif. FOE catalyzes the 
oxidation of cysteine in formylglycine residue (Cosma et aI., 2003) (Dierks 
et aI., 2003). This modification is fundamental for the activation of 
sulphatases (Selmer et aI., 1996). Failure to generate FOly, as found in 
patients with mutations in the FOE-encoding SUMF1 gene, leads to 
multiple sulfatase deficiency (MSD), a rare but fatal inherited disorder that 
is characterized by synthesis of catalytically inactive sulfatases (Cosma et 
aI., 2003) (Dierks et aI., 2003). ERp44 interacts via Cys29 with CysSO 
and/or CysS2 in the N-terminal domain of FOE. Von Figura and co-
workers clearly showed that increasing ERp44 levels by over-expression 
improves and reducing ERp44 levels by silencing decreases the 
intracellular retention of FOE (Mariappann et aI., 2008) 
1.3.2 ERp44 
In 2002, ERp44 was first identified as a protein involved m oxidative 
protein folding (Anelli et aI., 2002). 
ERp44 is a member of the PDI-family and is composed of an ammo-
terminal thioredoxin (TRX) domain a, endowed with a -CRFS- motif, 
followed by two redox inactive TRX-like domains, band b', and contains a 
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carboxyterminal ER retrieval signal (-RDEL). Having a CRFS motif, ERp44 
cannot act as an efficient oxidoreductase. 
ERp44 homologues are present in Mus musculus (89% sequence identity), 
Drosophila melanogaster (51 % identity), Caenorhabditis elegans (three 
hypothetical protein in which C30H7.2 displays a closest homology 45% 
identity). In Saccharomyces cerevisiae, the proteins with higher homology 
with ERp44 are Pdilp and Euglp, but identity is lower (-25%) and 
restricted to the TRX -like domain a. 
ERp44 forms mixed disulphides via Cys29 (CRFS) in the Trx domain a 
(Anelli et aI., 2003). When Cys29 is replaced with Ser, the formation of 
mixed disulphides with endogenous partners is prevented (Anelli et aI., 
2003). ERp44 contains six cysteines: mass spectrometry analyses revealed 
that the four C-terminal cysteines are covalently linked in sequential pairs 
(Anelli et aI., 2002) whereas two are present as thiol (Cys29 and Cys63 in 
the domain a). 
ERp44 contributes to retain Erola and Erolp intracellularly, the two rate-
limiting factors in PDI oxidation (Sitia et aI., 2001), by forming mixed 
disulphides (Otsu et aI., 2006). Moreover, ERp44 may play a role in the 
regulation of redox activity these proteins (Anelli et aI., 2002). Similarly, 
ERp44 forms transient disulphides with IgM subunits (Anelli et aI., 2002, 
2003) (Anelli et al., 2007), adiponectin (Wang et aI., 2007) or 
formylglycine-generating enzyme (FGE) (Mariappan et aI., 2008), 
regulating their transport. 
Recent evidence suggests that ERp44 is partly localized in ERGIC 
compartment and it is non-covalently bound to ERGIC-53 (Gilchrist et aI., 
2006) (Anelli et aI., 2007). The localization of ERp44 also reflects its 
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capability of interacting with ERGIC-53. The ER-localized KKAA mutant of 
ERGIC-53 recruited endogenous ERp44 m this compartment. 
Nonetheless, some ERp44 is found in the ERGIC of the KKAA 
transfectants, which lack detectable ERGIC-53 in this compartment 
(Vollenweider 1998). By concentrating distally with respect to PDI, ERp44 
and ERGIC-53 receive intermediates of assembly (lgM subunits) (Anelli et 
al., 2007) that have completed the first step in the production line, that is 
the SiP-dependent fJ2A2 assembly (Hendershot and Kearney 1988)(Sitia et 
aI, 1990); supporting the oligomerization within ESC. 
Consistent with its role in folding and transport in the secretory pathway 
(Anelli et aI, 2002) (Anelli et al., 2003) (Anelli et al., 2007), ERp44 is 
induced during ER stress and abundantly expressed in secretory tissue 
cells (Human Protein Atlas; www.hpr.se). 
In addition to its crucial role in thiol-mediated retention and quality 
control, ERp44 interacts with inositol 1,4,5-trisphosphatereceptor type I, 
inhibiting its Calcium channel activity (Higo et al., 2005) (see 1.4). 
1.3.3 ERGIC-53 
ERGIC-53 belong to a class of type I transmembrane sorting receptors 
(Appenzeller-Herzog & Hauri 2006) and consist of an L-type lectin domain, 
a stalk domain, a transmembrane domain, and a short cytoplasmic 
domain. ERGIC-53 forms disulfide-linked homodimers and 
homohexamers through 2 cysteine residues in the stalk domain. (Lahtinen 
et aI., 1999) ERGIC-53 mainly localized in ERGIC and is continuously 
shuttled from ER to ERGIC. Indeed, ERGIC-53 has a C-terminal KKFF di-
lysine ER-targeting signal that binds to COP I proteins and is required for 
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recycling. Two C-terminal phenylalanine residues in the short cytosolic 
domain are also necessary for the proper trafficking of ERGIC-53 from the 
ER (Nufer et al., 2002). ERGIC-53 traffics between the ER, where it 
captures soluble glycoproteins, and the Golgi complex, where it releases 
them thanks to lower Calcium concentration and pH (Appenzeller-Herzog 
et al., 2004). These two factors in fact regulate both the protonation of a 
conserved histidine in the ERGIC-53 lectin domain and its interaction 
with other regulatory proteins, such as MCFD2 (Hauri et al., 2000) 
(Appenzeller-Herzog et al., 2004) (Kawasaki et al. 2008). Its cargo is a 
specific subset of glycoproteins, including blood coagulation factors V and 
VIII (Zhang et al. 2003), two lysosomal enzymes glycoproteins cathepsin Z 
(Appenzeller et al., 1999) and cathepsin C (Vollenweider 1998) (Nyfeler et 
al., 2006), procathepsin Z (Appenzeller-Herzog & Hauri 2006), and alpha 
I-antitrypsin (Nyfeler et al. 2008) .. Besides, ERGIC-53 is also involved in 
the traffic of IgM (Mattioli et al. 2006) (Anelli et aI., 2007), and Sulfatase 
modifying factor 1 (Fraldi et al. 2008). 
Sitia and co-workers showed the concerted action of ERp44 and ERGIC-53 
in IgM polymerization (Anelli et al., 2007): hexameric ERGIC-53 may 
provide a planar platform that concentrates j.!2A2 subunits and favours 
their ordered assembly (Fig. 1.13), avoiding formation of larger polymers 
(Lalla & Sitia, 1998). In support of this model, the inactive NI56A mutant 
inhibits polymerization, likely because hetero-hexamers (with endogenous 
wt molecules) with reduced valency are formed (Anelli et aI., 2007). 
Consistently with its role in regulating the transport of coagulation factors 
V and VIII, the gene that encodes ERGIC-53 has been identified as a gene 
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responsible for the autosomal receSSIve bleeding disorder combined 
deficiency of coagulation factors V and VIII (F5F8D)(see 1.5). 
1.4 ESC and signalling 
Often, intracellular signalling is triggered by an external ligand targeting a 
Elasma Membrane (PM) receptor. The signal is then transduced into and 
propagated through the cell by a well-characterized cascade that involves 
specific protein categories, such as kinases, phosphatases, lipases and 
GTPases. Over the last decade, several studies reported the presence of 
these signalling proteins on different intracellular organelles, including 
endosomes, ER, Golgi complex, mitochondria, and the nuclear membrane 
(Sallese et al., 2009). 
The ESC is indeed a crossroads of at least three signalling pathways: 
signalling from KDEL receptor, unfolded protein response and Calcium 
signalling. 
1.4.1 Signalling from KDEL receptor 
Sallese and co-workers studies (Pulvirenti et al., 2008) uncovered a 
signalling reaction that is initiated by a Golgi-localized signal-receptor 
system that senses, and is activated by transport carriers arriving at the 
Golgi complex from the ER. This triggering signal is provided by the ESC 
chaperones. As these chaperones reach and enter the GC they bind to and 
'activate' the KDEL receptor (KDEL-R) through their KDEL motif (Munro 
Pelham 1987). The KDEL-R is a seven-transmembrane domain-containing 
protein that once activated, dimerizes, changes conformation within the 
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membrane, and recruits the COPI trafficking machinery. These then move 
retrogradely, thus recycling the chaperones to the ER, from where the 
KDEL-R can again shuttle between the ER and the Golgi complex. KDEL-R 
binding to ESC chaperones could initiate activation of the Src family 
kinases (SFKs), and hence a SFK-dependent tyrosine phosphorylation 
cascade on the Golgi complex (Pulvitrenti et aI., 2008). In turn, this 
activates the intra-Golgi transport machinery, and thus balances the 
membrane input to the Golgi that initiates the whole process with an 
increased membrane output from the Golgi complex. Although, the way in 
which the exit of the chaperones from the ER is linked with, or regulated 
by, the efflux of cargo from the ER remains to be determined, once in the 
Golgi complex, the chaperones can activate a KDEL-R-dependent 
phosphorylation cascade that controls intra-Golgi trafficking. 
At its most basic level, this chaperonejKDEL-RjSFK mechanism provides 
a simple feed-forward circuit that can result in positive gating of the Golgi 
complex, and that helps to preserve the dynamic equilibrium of the Golgi 
complex during trafficking 
This chaperonejKDEL-RjSFK system might be a 'universal' traffic-
regulatory device. This is suggested by the ubiquitous nature of 
chaperones, which would allow them to serve as general trafficking signals 
in all cell types, and is further supported by the dependence of membrane 
trafficking on the SFKs that has been seen in all cell lines tested to date 
(Pulvirenti et aI., 2008) (Fig. 1.15). 
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F'rom Pulvirenti et al ., 2008 
Figure 1.15. Model of traffic self-regulation by t he c haperone-KDEL-
R-SFK signal response system. 
Chaperones containing KDEL sequences (red triangles) leave the ER 
with cargo (black sticks). On arrival at the cis-Golgi, they bind the 
KDEL-R (green Pacmen), triggering activation of SFKs on the Golgi 
complex. This activation may occur by direct interactions between the 
KDEL-R and Golgi SFKs or by a more complex mechanism. In turn, 
these p -SFKs induce a phosphorylation cascade (violet arrows) that is 
required for the trafficking machinery to function for the subsequent 
in tra -Golgi transport. 
1.4.2 Unfolded protein response 
ER stress can be induced by a variety of physiological conditions, 
induding perturbations In calcium homeostasis, glucose/energy 
d privation, redox changes, ischemia, viral infections and protein 
mutations, i all viated by the Unfolded Protein Response (UPR) 
(Kaufman 2002) (Szegezdi tal., 2006 )(Fig. 1.16). 
P rturbations th t alter ESC homeostasis might disrupt folding and lead 
to th accumul tion of unfold d prot ins and protein aggregates, which 
ar d trim nt 1 to c 11 survival. 
Hul r 1 v 1, th d ptiv pha of th UPR triggers three kinds of 
pr t ti Uul r pon 
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(i) Up-regulation of ESC chaperones such as BiP/GRP78 to assist in 
the folding-assembly of proteins (Kaufman 1999) is a longer-term 
adaptation that entails transcriptional activation of UPR target 
genes; 
(ii) Reduction of the protein load that enters the ER, which is a 
transient adaptation that is achieved by lowering protein 
synthesis and translocation into the ER. This attenuation of 
protein translation is mediated by the serine-threonine kinase 
PERK (protein kinase-like endoplasmic reticulum kinase) which 
phosphorylates the initiation factor-eIF2a thereby reducing 
translation (Prostko et al.,1993); 
(iii) Degradation of misfolded proteins by the proteasome by a 
process called ER associated degradation (ERAD) (Hampton, 
2002) 
ESC triggered signalling pathways through three proximal sensors of the 
unfolded protein response, inositol requiring element-l (IRE-I), PKR-like 
ER kinase (PERK) and activating transcription factor 6 (ATF6) in the ER. 
Excessive and/prolonged stress leads to a maladaptive response and 
apoptosis (Szegezdi et aI., 2006). 
ATF6, PERK and IREl are integral membrane proteins constituted by a 
luminal portion that sense the protein-folding environment in the ER, and 
by a cytoplasmic effector portion that interact with the transcriptional or 
translational apparatus in the cytosol and in the nucleus. 
All three of these sensors are maintained in an inactive state at the ER 
membrane by binding to BiP. Upon accumulation of unfolded proteins, 
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bound BiP dissociates from ATF6, IRE-I and PERK to chaperone the 
misfolded proteins thereby permitting the activation of one or more of 
these transducers (Szegezdi et aI., 2006). BiP therefore serves as the 
master regulator of the UPR. 
PERK is a type I transmembrane serine threonine kinase. When activated, 
PERK homodimerizes and self-phosphorylates, thereby activating itself 
and initiating its eIF2a kinase activity. Phosphorylation of the translation 
initiation factor, eIF2a, results in the formation of a stalled 43S ternary 
complex that causes a general decrease in the translation of most 
proteins. However some selected proteins with internal ribosomal entry 
sites (IRES), such as ATF4, GRP94 and BiP, are translated more efficiently 
(Harding et aI., 2000) and hence their protein levels actually increase. 
Once activated, the cytoplasmic domain of IRE-la gains endoribonuclease 
activity and cleaves 26 nucleotides from the mRNA encoding X-box 
binding protein (XBP) I, generating a spliced variant (XBP-l s) that 
functions as a potent transcriptional transactivator of genes involved in 
ER expansion, protein maturation, folding and export from the ER, as well 
as export and degradation of misfolded proteins (Yoshida et al., 200 I) 
(Calfon et aI., 2002)(Yoshida et aI., 2003). IRE-I may also degrade ER-
targeted mRNAs, thus decreasing the production of new proteins in the 
organelle (Hollien & Weissman 2006) (Pirot et aI., 2007). ATF6 signalling 
and transcription of ER chaperones ATF6 is a 90-kDa-bZIP protein that is 
activated by post-translational modifications. ATF6 activation as part of 
the UPR leads to its translocation to the Golgi and cleavage by site-l 
protease (SIP) and S2P. The 50-kDa cleaved ATF6a translocates to the cell 
nucleus, where it binds to the ER stress response element CCAAT (N) 
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9CCACG (Yoshida et aI., 1998) in genes encoding ER chaperone proteins 
such as BiP and GRP94. This results in increases in the level of these 
proteins and hence increased protein folding activity in the ER (Okada et 
al., 2002). 
( 
'f 
From Szegezdi et al. 2006 
Figure 1.16. The unfolded protein response 
On aggregation of unfolded proteins, GRP78 dissociates from the three ER 
stress receptors, PERK, ATF6 and IRE1, allowing their. This concerted 
action aims to restore ESC function by blocking further build-up of client 
proteins, enhancing the folding capacity and initiating degradation of 
protein aggregates . 
1.4.2 Calcium signalling from ER 
Th ER is the most important intracellular Calcium store that can 
accumulate it to concentrations of 10-100 mM, while its concentration in 
the cytoplasm of the resting cell remains within the range of 100- 300 nM 
(6rlach tal., 2006). Upon stimulation of plasma membrane (PM) 
r c ptor or upon I ctrical excitation of the PM, the ER releases Calcium, 
thu particip ting in th g n ration of rapid Calcium signals. ince the ER 
torag ap city i limit d, Calcium reI as must be followed by Calcium 
r pl ni hm nt. al ium mov ments across th ER membrane are 
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facilitated by three classes of proteins: Calcium release channels inositol-
1,4,5-triphosphate (IP3) receptors (IP3Rs) (Bezprozvanny 2005)(Mikoshiba 
2007) and ryanodine receptors (RyRs) (Hamilton 2005), Calcium re-uptake 
pumps-sarco-endoplasmic reticulum Calcium-ATPases (SERCAs) 
(Periasamy & Kalyanasundaram 2007) and luminal Calcium-binding 
proteins, such as calsequestrin, sarcalumenin, histidine-rich Calcium-
binding protein, calreticulin. 
There is substantial evidence of a cross interaction between the ER redox 
state and Calcium homeostasis (Fig. 1. 17): 
• At high ER Calcium concentration and oxidizing condition, ERp57 
(in association with calreticulin) interacts with SERCA2b, 
inactivating the pump by oxidation, while RyRs and IP3R 1 are open. 
(Li & Camacho 2004). 
• At low ER Calcium concentration and reducing conditions, ERp44 
directly inhibits the channel IP3R1 (Higo et aI., 2005) and 
calsequestrin (CSQ) inhibits the channel RyR (Szegedi et aI., 1999). 
It has been reported that ERp44 can directly interact with the third 
luminal loop (L3V) of IP3R type 1 (IP3R1) to inhibit its channel activity in a 
pH-, redox state and ER Calcium concentration dependent way (Higo et 
aI., 2005). Indeed, a short region of ERp44 rich in glutamic acid residues 
(from 207 to 256), which shows no sequence similarities with other known 
proteins but is well-conserved among species, was reported to be 
necessary and sufficient for the interaction with the IP3Rl. 
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SER ,A,2b 
wOrki n 
low [Ca2+]h.m (10-100mM) 
reducing conditions 
SERC 2 
ot-workin 
High [Ca2-+]1un (80-200mM) 
oxidizing conditions 
Figure 1.17. Overview of ,cross interaction between t he ER redox 
state and Calcium homeostasis. 
CRT: Calreticulin; RyR: Ryonidin receptor; Cyt: cytosol; CSQ: 
Calsequestrin. See text for details 
1 .5 ESC processing diseases 
Little is known about the overall efficiency of protein folding and assembly 
in the ESC. A number of examples describe a wide range from very high 
efficiency observed with viral proteins (e.g. vesicular stomatitis virus 
glycoprotein is about 90%-(Mathieu et al., 1996) to very low efficiency for 
ion channels (cystic fibrosis transmembrane conductance regulator, 
CFTR- about 20%-(Kopito et al., 1999) 
Lik wise, ov ra1l protein produ ction m the ESC may not be of high 
efficiency and dedicated machinery is built into the folding and assembly 
machine of the ESC to degrade/remove non-native proteins and thus 
pr v nting intrac llular protein accumulation and aggregation. 
57 
1.5.1 ESC processing diseases: loss of function 
Mutations in proteins that impair their proper folding are a common 
reason for the development of ESC processing diseases. 
A deletion of phenylalanine at position 508 in CFTR IS the cause for 
disease in up to 80% of cystic fibrosis patients (Gadsby et aI., 2006). The 
de stabilized mutant protein is retained in the ER and eventually degraded 
and thus, trafficking to apical plasma membranes in ducts and airway 
epithelia is prevented. As a result, the function of CFTR as a chloride 
channel is compromised. Loss of CFTR function alters the hydration of the 
mucosal layer that lines the airway epithelia leading to persistent bacterial 
growth and development oflung fibrosis (Rowe et aI., 2005). 
In al antitrypsin (alAT) deficiency, mutant alAT Z cannot be secreted by 
hepatocytes into the blood and body fluids, where it normally inhibits 
neutrophil proteases. As a consequence, proteases degrade the connective 
tissue matrix of the lung causing emphysema (Gooptu & Lomas 2009). 
This is a clear case of overzealous QC, in that alAT Z retains enzymatic 
activity but cannot deploy it owing to intracellular retention. 
Likewise, loss of function derived from folding problems in a variety of 
proteins leads to retention of mutated proteins and their degradation 
(Aridor 2007). 
1.5.2. ESC processing diseases: Gain of function 
In addition to loss-of-function derived from the inability of such protein to 
be sorted in its final destination, a gain-of-function occurs when the ESC 
is unable to dispose the mutant proteins. Many human diseases are 
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characterized by the presence of protein aggregates in the lumen of the 
ESC sub-regions. As a result, it may lead to toxicity and cell death. 
Hereditary hemochromatosis (HH) is a recessive disorder characterized by 
pathological abnormal iron accumulation in tissues. The pathology is due 
to a cysteine to tyrosine substitution in HFE folding and association with 
~2 microglobulin (Gray et aI., 2009). Impaired assembly prevents surface 
expression of HFE, the majority of the mutant protein remaining in the 
Esc, as high molecular weight aggregates (Gray et aI., 2009). 
Abnormal plasma cells (Mott cells) displaying dilated, Ig-containing ER 
cisternae (Russell Bodies, RB) are present in some non-secretory 
myelomas and in autoimmune or inflammatory diseases (Jiang et aI. 
1997). RB form when mutant Ig is produced that can neither be secreted 
nor degraded (Kopito & Sitia 2000) (Mattioli et aI., 2006). 
In the absence of A chains, ll~CH 1 (~ lacking the BiP-binding CH 1 domain) 
condenses in ERGIC-derived tubular structures (smooth RB, sRB). In its 
presence, larger, ribosome-coated vesicles (rough RB, rRB (Mattioli et aI., 
2006) are formed. rRB and sRB likely reflect abnormalities in the proximal 
and distal QC steps assisting IgM polymerization. 
The observation of Mott myelomas with RB and the capability of selecting 
B cells with aggregation imply that cells can coexist and proliferate with 
abundant aggregates in their ESC. Why do other aggregates cause 
disease? A possible explanation is that cell division generates space for 
accommodating aggregate-containing vesicles. In a tissue where instead 
proliferation is limited by space constraints, the accumulation of dilated 
ESC cisternae is instead bound to cause problems to the cell and its 
neighbours. 
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1.5.3 ESC processing diseases: machinery diseases 
Mutation in ESC-protein folding crew can also lead to ESC-derived 
diseases. Highly specific defects develop as observed in cranio-Ienticulo-
sutural dysplasia (CLSD) (Boyadjiev et aI., 2006). Orci and co-workers 
showed that CLSD occurs as a result of defective COPII-mediated 
endoplasmic reticulum export owing to loss of function of SEC23A. As a 
result, collagen and (probably) other secretory proteins accumulate and 
enlarge the ER, ultimately leading to the clinical manifestations of CLSD. 
The relatively mild phenotype of affected individuals suggests that the 
ll44T-C SEC23A mutation is a hypomorph and that the mutant protein 
retains some residual functional activity (Boyadjiev et aI., 2006.) 
Mutations that disrupt the SILl function (also called BAP) protein cause 
Marinesco-Sjogren syndrome (MSS) (Senderek et al. 2005), a form of a 
cerebellar ataxia complicated by cataracts, developmental delay and 
myopathy. SILl acts as a nucleotide exchange factor for chaperone BiP, 
which is a key regulator of the main functions of the ER. 
Loss-of function mutations in ERGIC-53 protein cause a recessive 
bleeding disorder characterised by decreased levels of two glycoproteins 
(Combined Deficiency of Coagulation Factors 5 and 8, F5F8D) (Zhang et 
al. 2003) (Spreafico & Peyvandi 2008). In other F5F8D patients, mutations 
are localized in MCFD2, a protein that associates with ERGIC-53 (Zhang 
et aI., 2003). Despite that ERGIC-53 is involved in many processes 
including IgM polymerization, SUMFl folding/transport and alAT traffic, 
only Factors 5 and 8 traffic is crucially dependent by ERGIC-53 
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suggesting compensatory mechanisms and/ or redundancy In the ESC 
quality control crew (VIPL and VIP36). 
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2.Aims of the work 
ERp44 plays a key role in Ihiol-Mediated Retention (TMR) of variety of 
client proteins (Ero1a-Anelli et aI., 2002; Anelli et aI., 2003. SUMF1-
Mariappan et aI., 2008; Fraldi et aI., 2008. Adiponectin-Wang et aI., 2007. 
IgM-Anelli et aI., 2007; Cortini & Sitia 2010) and thus, regulating their 
transport and localization. Besides being fundamental to the quality 
control system, ERp44 interacts with IP3R1 (Inositol trisphosphate 
receptor 1), inhibiting its activity and thus, regulating the efflux of calcium 
ions from ER (Higo et aI., 2005). Altogether these features make the 
ERp44 a candidate to integrate transport protein signalling and redox 
homeostasis. 
Several open questions remain to be investigated: 
I. What is the three-dimensional structure of ERp44? 
H. How does monomeric ERp44 find the oxidative power to form 
disulfide bonds with its substrates? 
Ill. Which is the molecular basis ofTMR of ERp44? 
IV. How is ERp44 regulated in living cells? 
The overall aim of this work is to obtain more insights into the 
mechanisms of ERp44-TMR, by means of structural and functional 
approaches. 
First of all, a recombinant form of human ERp44 was produced and 
purified to homogeneity. This material was used for crystallization studies 
aimed at the determination of the three-dimensional structure of ERp44 
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using X-ray crystallography. The availability of high-resolution structure 
of a protein is mandatory for understanding its structure-function 
relationship. It is particularly important to assess at the atomic level the 
role of the individual domains of ERp44 in modulating its diverse 
functions. Moreover, three-dimensional structure provided a solid 
framework for the design of protein mutants of ERp44. 
Exploiting a combination of different approaches, structure-based 
functional analysis aimed to elucidate the molecular mechanisms of 
ERp44 regulation. While X-ray crystallography could produce valuable 
high-resolution information on stable conformations of macromolecules, it 
cannot readily provide information on dynamics. Thus, we used a 
combination of in silico mutagenesis and molecular dynamics (MD) to gain 
insights into the role of specific amino acid residues of the dynamic 
regulation of ERp44. 
In addition, ERp44 mutants devised from both the structure and in silico 
experiments were extensively characterized. ERp44-mediated Ero la 
retention/interaction was exploited as main assay to assess the role of 
ESC pH on ERp44 physiology and to determine the role of individual 
domain/region/residues in TMR activity. 
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3. Results 
3.1 ERp44 production, purification and c rystallization 
3 .1.1 Protein production in E.coli 
A preliminary bioinformatic analysis of human ERp44 protein sequence, 
differently from what previously reported (Anelli et al., 2002) (Anelli et al. , 
2003)(Higo et al ., 2005), revealed that it contains aN-terminal TRX-like 
domain, similar to that of PDI a, with a -CRFS- motif followed by two 
redox-inactive TRX-like domains, homologous to the b and b ' domains of 
PDI (Fig. 3.1). 
POI a 1 e-51 POI b 3e-34 
Figure 3.1 ERp44 domain organization 
Bioinformatic analysis of human ERp44 protein sequence by Conserved 
Domain Database (CDD) (Marchler-Bauer et al., 2005) reveals that it 
contains a three TRX-like domain , s imilar to PDI (see E-value). Orange 
balls ar cys residues in domain a. Cys 29 mediates covalent interaction 
with cli nt proteins (Anelli et a I. , 2002) . The three thioredoxin-like 
domain ar followed by a disordered C-Tail of 52 residues (from 325 to 
373) and by - RDEL motif for ESC retrieval. The Signal Eeptide (yellow 
box) is cl av d upon entry in the ER, yielding the mature form of ERp44 
(1 -377). E-rich r gion, depicted in blue, mediates the interaction with 
IP3R1. 
The thre thioredoxin-like domains are followed by a disordered C-Tail of 
52 r idu (from 325 to 377 residues) (Fig. 3 .2) with no obvious sequence 
homology with oth r proteins (Fig. 3.1 ) The cDNA fragmen ts encoding the 
full -l ngth ERp44 (without - RDEL C-t rminal motif and N-terminal signal 
p ptid ) w Ion d into a pET-28b v ctor, allowing the expression of a 
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hexahistidine tag fused to the N-terminus of the recombinant protein for 
expression in E. coli (Fig. 3.3). 
:. ~----------~----~------~------------------~ Trx a Trx b Trx b C-Tail 
Rulduo Po on 
Figure 3.2. Probability of disorder for human ERp44 
RONN (Regional Order Neural Network) pI t (Yang et al., 2005) of disorder 
probability per residue for ERp44. The h orizontal dashed lines mark the 
threshold for disorder prediction. C-terminal tail was predicted to be highly 
disordered. 
wt I I a b b' 
!1Tail 
~----~----~----~ 
T369A 
T369A 
C29SC63S 
sxxs 
!1TRX b' 
Figure 3.3. ERp44 protein produced in E. coli 
h m ti r pr nt tion of ERp44 clon d in pET28b vector fo r E. coli 
xpr lOn. r y quar t N-t rminus r pr s nts His-tag. Black 
ir 1 indi t d po in mut tion . 
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Among the SiX cysteine residues which ERp44 consists, four cysteine 
residues form two disulfide bonds and the other two sulfhydryls are 
predicted as free thiols (Anelli et aI., 2002). 
ERp44 wt was expressed in E. coli BL21 (DE3) and Rosetta-gami 2TM 
(DE3). The latter strain is one of BL21 derivatives and is designed for 
enhancing the expression of eukaryotic proteins (these proteins contains 
codons rarely used in E. call) and the formation of target protein disulfide 
bonds in the bacterial cytoplasm. Our first attempts to express ERp44 
protein in both strains indeed led to low levels of soluble protein (not 
showed). Lowering of the IPTG concentration to 0.1 mM and changing the 
induction temperature to 20°C resulted in extremely high yields on soluble 
protein (Fig. 3.4, lanes 1 and 2). BL21 (DE3) produced more recombinant 
protein than Rosetta-gami 2TM (DE3), and thus, BL21 (DE3) was chosen 
for the following large scale expression of recombinant ERp44 (Fig. 3.4-
Lane 1). 
BL21 Rosetta-Gami 2 
IPTG (mM) 0.1 0.5 0.1 0.5 
• 
2 3 4 5 {\ 7 8 9 10 11 12 
s ps pps sp s ps p 
Figure 3.4. ERp44 protein production 
Coomassie of SDS-page of E. coli lysates (BL21 and Rosetta-Gami 2, as 
indicated) expressing ERp44wt 0 IN induced with different concentration 
of IPTG, as indicated. The lysates are divided in soluble fraction (S) and 
insoluble fraction (P). The insoluble fraction is re suspended in SDS-page 
loading buffer. Asterisk indicated His-tag ERp44. 
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3.1.2 Purification of recombinant His-ERp44 
The pET28-ERp44 plasmid was used to transform E. coli BL21(OE3) to 
obtain an amount of purified recombinant protein sufficient for extensive 
crystallographic characterization. The purification of ERp44 was achieved 
through sequential chromatographic steps. Initially, the polyhistidine tag 
was utilized for affinity chromatography using Ni-NTA resin. After elution, 
all the collected fractions were analyzed by SOS-page before pooling them 
together. A high degree of purity was achieved in this first purification 
step, as confirmed by the presence of a single well defined band at about 
45 kOa when purification is performed in reducing condition (1 mM 2ME) 
(Fig. 3.5a- panel "Ni-NTA red"). Indeed, several bands co-purify with 
ERp44 when Ni-NTA purification was performed under non-reducing 
conditions, indicating the formation of covalent complexes between ERp44 
and different endogenous proteins in E. coli (Fig. 3.5a- panel "Ni-NTA 
Nred"). 
The samples were further purified through a SIze exclusion 
chromatography (gel filtration), using a Superdex 200 HR 10/30 column, 
the protein eluted with a wide peak (Fig. 3.5b- in blue), consistent with the 
presence of both covalent dimer of ERp44 and non-specific mixed disulfide 
complexes. Conversely, when all purification steps were performed in 
reducing conditions, the protein eluted at a retention volume 
corresponding to a molecular weight of 50 kOa consistently with a 
monomeric protein (Fig. 3.5b in red). The recovered recombinant protein 
was incubated with thrombin and the quantitative removal of the 
polyhistidine tag was assessed by Coomassie staining and protein blot 
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with the anti-His probe (Fig. 3.5c) . A further size exclusion 
chromatography was necessary to separate thrombin, the fusion tags, and 
any possible product of degradation from the recombinant protein of 
interest. The final yield of ERp44 was 15 mg of pure protein per litre of 
bacterial culture. The sample was 95% pure as estimated by SDS-page 
(Fig. 3.5a panel "post-FPLC Red"). 
a 
Ni· NTA Red Ni·NTA Nred 
Figure 3.Sa. ERp44 purification 
A. NTA ERp44 protein purification. Coomassie SDS-page of elution 
fractions of a Ni-NTA purification of ERp44, performed in reducing (R) or 
non-reducing (Nred) conditions, as indicated. The lane labelled as "Post 
FPLC Red" shows the purity of the protein after size exclusion 
chromatography. Blue arrowhead indicates ERp44 
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Figure 3.Sb and c. ERp44 purification 
B. Size xclusion chromatography ERp44 purification. Size exclusion 
chromatograms of pooled Ni-NTA purification fraction performed in 
r ducing condition (R; red line) or non-reducing condition (NR; blue line). 
C. R moval of His- tag from ERp44 fusion protein with thrombin. 
Combination of time and Thrombin/protein ratio monitored by Coomassie 
(upp r pan 1) and protein blot (a-His tag-bottom panel). Upon His-tag 
r moval, ERp44 und rgoes a small MW shift in Coomassie and is not 
d t ct d nymore by a-his antibodies in protein blots. The used protocol 
for larg cal cleavag is 24 h with 1: 1000 thrombin:protein ratio. 
J2yn am ic 1ight _ cattering (DLS) 1S widely used to assess the 
monodi p r ity of th sampl. Inde d, the level of polydispersity 
d t rmin ed b DL is r lat d to th likelihood of crystallization: a 
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positive correlation of low (generally ~ 20 %) polydispersity of a gIven 
protein sample and the tendency to crystallize had been described (D'arcy 
1994)(Ferre-D'Amare and Burley 1994). DLS measurements performed at 
4°C and 20°C at several concentrations of ERp44 indicated a 
hydrodynamic radius of 3.52 nm (± 0.1) nm (deduced molecular weight of 
60 kDa), with polydispersity of 15% confirming the monomeric state of 
ERp44. The protocol of purification established for the wild type protein 
was also used for all the mutants of ERp44 generated in this study. 
3.1.3 Crystallization, diffraction improving and data collection 
Several different conditions from Crystal Screens FM and IITM and Index 
Screen™, Salt RXTM, Membrane frac™ yielded single crystals. Diffraction-
quality crystals of ERp44 grew in conditions optiinized from Crystal 
Screen I condition n 029. Single crystal prisms typically appeared after 48 h 
in 0.85 M Na/K Tartrate 0.1 M Tris-Cl pH 8.5 and grew to maximum 
dim nsions of 0.3 x 0.3 x 0.5 mm in 4 days (Fig. 3.6). 
b 
Figure 3.6 ERp44 crystals 
Pic ur of full 1 ngth ERp44 crystals (A-his-tagged ERp44. B-native 
ERp44). 
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The native crystals diffracted to 5.0 A in house. One native data set was 
collected to 4.0 A at the beam line ID29 of the European Synchrotron 
Radiation Facility in Grenoble (France) (Fig. 3.7). These crystals belong to 
the trigonal space group P3121 or P3221, with unit-cell parameters a = 
88.36, b = 88.36, c = 135.04 A and a= 90°, p= 90°, y= 120°. The unit cell 
volume is consistent with one molecule of ERp44 in the asymmetric unit 
(Table 3.1). 
Data collection 
Resolution range (A) 
Wavelength (A) 
Space group 
Cell dimension 
50-4 
0.97372 
P321 
a,b,c(A) 88.36, 88.36,135.06 
a,~,y (") 90,90,120 
Completeness (%) 93.8(69.4) 
Rsym (%) 9.7(40) 
1/0 (6) 
Total reflections 42761 
Unique reflections 5139 
Table 3.1 Statistic for ERp44 His-tag 
In parallel, a SeMet derivative of the protein was produced following the 
method of Liu et al., (Liu et al., 2005) Quantitative SeMet incorporation 
was confirmed by mass spectrometry (data not-showed). Although, the 
SeMet preparation yielded crystals under very similar conditions as the 
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wild type protein, but no SAD (single-wavelength anomalous dispersion) 
data set could be collected since crystals of the SeMet-labeled ERp44 did 
not diffract to high resolution. 
a 
, . 
. 
~ .... : 
b 
homodimer. 
. .. 
• 
, " monom er • •• pr . 
1 2 
Figure 3.7. ERp44 diffraction analysis 
Co vale nt 
complexes 
A. Diffraction pattern of the ERp44 crystals which diffracted to barely 
beyond 4 A resolution (ESRF ID-29). 
B. ERp44 crystal SDS-page non-reducing SDS-page coomassie of protein 
crystals and protein in solution as indicated. Arrows indicate monomeric 
and homodimeric protein while disulfide complexes are indicated with 
bracket. 
SDS-page in non-reducing conditions of dissolved ERp44 crystals revealed 
that the protein, during crystallization process, partially forms disulfide 
complexes (Fig. 3.7b- lane 2). Indeed, this could create mIcro 
heterogeneity in the crystal lattice and therefore affects the diffraction 
quality. DLS analysis revealed that after 3-4 days of storing at 4° (not-
showed), mono mer ERp44 partially forms homodimers confirming that 
ERp44 is reactive also in solution (Fig. 3.7b- Lane 1). To overcome this 
situation, we added 5 mM DTT before crystallization but, unfortunately, 
this was not enough to keep ERp44 reduced along equilibration period. 
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Three strategies were exploited to improve crystal quality and diffraction: 
A. Improve crystallization conditions 
An extensive optimization screenmg was performed usmg Detergent 
Screen, Additive screen, exploiting different crystallization methods (4-20° 
C temperature, sitting drops). We obtained protein crystals from other 
conditions without any valuable improvements in diffraction. 
Then, we exploited well-established post-crystallization methods to 
improve crystal quality: 
a- Crystal glutaraldehyde cross-linking 
Crystal cross-linking increases the robustness of the crystal against 
mechanical stress, reduces its solubility and can also improve diffraction 
quality. We treated crystals with glutaraldehyde (vapour diffusion method 
with a variety % of cross linking agents) with little variations in the 
diffractive properties of the crystals. 
b- Crystal dehydration 
Crystallographers have investigated m detail the water-mediated 
transformations in protein crystals, and it is well appreciated that 
reduction of solvent content can produce more closely packed and better 
ordered crystals, extending the resolution of X-ray diffraction patterns 
(review in Heras & Martin 2005). Crystal dehydration emerges as the 
treatment that has produced the most remarkable improvements in the 
diffraction resolution of protein crystals (review in Heras and Martin 
2005). Indeed, in case of ERp44 we get small improvement not sufficient 
to obtain crystals to sufficient resolution. 
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B. Block the disulfide bond formation in ERp44 after purification 
We tried to alkylate free cysteine residues either with NEM (N-
ethylmaleimide) or with IAA (iodoacetamide) but after alkylation the 
protein respectively, aggregated or did not crystallize anymore. We 
changed the pH in drops from pH 8.5 to 6.5 to reduce the reactivity of 
cysteine residues, but we obtained small crystals that diffracted poorly. 
We used other reducing agents such as TCEP and l3-mercaptoethanol but 
we did not improve quality diffraction. We also designed two new mutant 
versions of ERp44 (Fig. 3.3) lacking of two free cysteine residues: 
a) ERp44 SXXS, where the two first reactive cysteines were 
replaced with serine residues. ERp44 mutant forms aggregates. Despite of 
our efforts we did not manage to obtain mono-disperse protein to 
crystallize. 
b) ERp44 ~TRX, where TRX-like a domain containing the two 
cysteine residues was removed. Although the protein was in monomeric 
state, extensive crystallization trials failed to obtain high quality crystal. 
In all cases we did not manage to improve diffraction-quality. Then we 
decided to exploit an other approaches to solve ERp44 crystal structure. 
C. Remove flexible region from ERp44 
The removal of flexible regions from protein is generally used to promote 
crystallization (Geiger et aI., 2008). It is self-evident that molecular 
flexibility will tend to be detrimental to the formation of a highly ordered 
crystal lattice. For proteins, such flexibility can arise from large-scale 
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motions of domains or portions of the polypeptide chain such as surface 
loops and chain termini. Such motions may be reduced or eliminated by 
redesigning the protein construct (for instance, by removing disordered 
terminal extensions) . In ERp44 the three thioredoxin-like domains are 
followed by a disordered C-tail (Fig. 3.2). Based on structural organization 
of ERp44 and limited proteolysis data (Braakman personal 
communication), we designed ERp44.6.Tail lacking the C-terminal floppy 
tail that may affects the crystallization (Fig. 3.2 and 3.3). Interestingly, a 
proteolytic fragment of full-length protein, indicated with a black arrow in 
Figure 3.8a, co-migrated with construct ERp44.6.Tail, indicating that the 
last 52 residues are susceptible to a protease digestion (Fig. 3.8a) as 
previously indicated by limited proteolysis data. 
a b 
PBS + PBS + 
0.5 M 0.5 M 
urea Na CI y'sis buffer: P8S 
ERp44 fl Tail 
--.--..:~---
ER 44wt 
s p s p 
s p s p s 
Figure 3.S. ERp44 .6.Tail is partially insoluble 
p 
PBS + 
O. % 
NP·40 
s p 
A. Protein blot (a-His) of a cell lysate in PBS of BL2l cells expressing 
ERp44wt or ERp44.6.Tail, as indicated. S: soluble fraction; P:insoluble 
fraction. Arrow indicated proteolytic C-terminal fragment of ERp44 wt. 
B. Protein blot (a-His) of a cell lysates with different buffers as 
indicated, of BL21 cells expressing ERp44.6.Tail. S:soluble fraction P. 
insoluble fraction. 
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The partial insolubility of ERp44 ~Tail (Fig. 3.8b) strongly suggests that 
this region, although disordered, is essential for the solubility of the 
protein at least in E.coli (see part 3.2 and 3.3). Despite extensive efforts all 
these crystals diffracted to 4 A. During the course of crystallization trials 
we became aware that the group of Wang in Beijing (China) was working 
on ERp44 crystal structure. Thus, we started a collaboration with them to 
join our efforts to solve the structure of human ERp44. 
Small motions such as those due to flexible, solvent-exposed amino acid 
side chains (such as lysine and glutamate residues) can be equally 
disruptive to a well-ordered crystal lattice (WaIter et aI., 2006). 
The most common approach to reduce surface entropy is the reductive 
methylation of free amino groups in which primary amines (Le., lysine 
residues and the N terminus) are methylated into tertiary amines. 
3.2 Crystal structure of human ERp44 
3.2.1 Overall structure 
The overall structure of ERp44 (Protein data bank accession number 
2R2J) resembles a clover composed of three domains (a-, b- and b'-) and a 
C-tail, which bridges b'- and a-, reSUlting in a quite compact appearance 
(Fig. 3.9 a and b). Domains a, b- and b'-shared the TRX-fold. The terminal 
tail (C-tail, residues 326-377) is highly flexible, ranging from the histidine-
rich loop through two short 310 helices: 114 (residues 326-328), and 115 
(residues 358-360) filling the cavity formed by a7 and a9 in b'-, short 
strand (316 (residues 369-370) anti-parallel to (33 in a-, and the ER-
retrieval -RDEL motif. 
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a b 
cl It· 
Figure 3.9. ERp44 crystal structure 
A. The structure, refined to 2 .6 A resembles a clover with three TRX-like 
domains (a, b and bl The C-tail bridges b' and a, resulting in a quite 
compact appearance. The C-tail (residues 326-377) is flexible, mainly 
composed of random coils. 
B. Surface representation of ERp44 . C-tail in red fills the cavity between 
a- and b- domains. Pictures for surface and cartoon were generated with 
Pymol. 
3.2 .2 Th -CRF - motif in domain a 
Th a domains of ERp44 and yPDI can be superimposed with a root-
m an- quar d viation (r.m.s.d) of 1.1 A against 104 aligned Ca atoms of 
otal 109 r sidu s, d spite the former having -CRFS- (residues 29-32) 
in tead of th canonical -CXXC- motif. The Cys29 sulphydryl forms 
h drog n bon with th hydroxyl of Ser32 in the quivalent position of 
64 in PDI, and the hydroxyl of Thr369 in th C-tail. The -CRFS- motif 
1 urround d by hydrophobic p tches imilarly to the one surrounding 
th - - m tif in yPDI, but i shi Id d by the C-tail (Fig. 3.10). Th 
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hydrophobic patch around the -CRFS- could also be involved In client 
protein binding, like in PDI (Tian et al ., 2006) . 
• hydrophobic pocket in domain b 
bydroph ic patch in 
C-tai l Ills th 
cavity 
Cys29 
Figure 3.10. C-tail shields Cys29 and hydrophobic pockets 
Cys29 (in orange) and hydrophobic pockets (in white) were shielded from 
th bulk solvent and almost inaccessible for the formation of 
int rmol cular disulfide bonds with client proteins. Pictures for surface 
wer gen rat d with Pymol. 
3 .2.3 A hydrophobic pocket in b' domain shielded by the C-tail 
In both human and yeast PDI, the b' domain is thought to be a primary 
ubstrat Binding _it (SBS) (Klappa et al., 1998) (Tian et al., 2006). A 
imilar h drophobic pocket in ERp44 is revealed by superposition of the b' 
dom in of ERp44 and yPDI with Lm.s.d of 1.7 A against 95 aligned Ca. 
tom out of 110 r idu s. In ERp44, this pocket is formed by three 
tr d ((j12, ~13 and (j14) at the bottom and two helices (a.7 and a.9) 
roun with di m t r of -16 A, a d pth of -5 A and a solvent-accessible 
f -200 2 quence alignment based on the structures of 
hER 4 d PDI indi t dth high similarity of the r idues composing 
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the hydrophobic pocket. The hydrophobic pocket in b'- and the adjacent 
hydrophobic patch in a- could act as a docking site for ERp44 
substrate(s). However, this region is partly covered by the C-tail turned 
back from b'- to a- (Fig. 3.10). The rJ3 of the C-tail settles onto the 
hydrophobic pocket like a lid with Phe358 and Leu361 protruding and 
offering additional anchors, which may drastically reduce the accessibility 
to client proteins. 
3.3 ERp44 C-tail rearrangements 
3.3.1 Substrate binding site accessibility 
The clover-like structure of ERp44 observed in the crystal structure most 
likely represents a non-reactive conformation of the protein (Fig. 3.9 and 
3.10). Indeed, Cys29 is shielded from the bulk solvent and almost 
inaccessible for the formation of intermolecular disulfide bonds with client 
proteins. The C-tail of ERp44 is actively shielding Cys29 and hydrophobic 
pockets in domain a and b'- (Fig. 3.10). 
To analyze whether the C-tail could have a regulatory role in substrate 
binding, we engineered a mutated ERp44 lacking the C-tail, hereafter 
termed ERp44~Tail (Fig. 3.13). 
First of all, we compared ERp44 and ERp44~Tail for their ability to 
suppress the aggregation of denatured rhodanese during refolding after 
dilution (Song & Wang 1995). Since rhodanese has no disulphide bonds, it 
is possible to analyze the chaperone-like activity of ERp44 or PDI, 
independently from redox activity. In Figure 3.11, ERp44 wt showed no 
chaperone-like activity (Fig. 3.11- compare red line to black line). 
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Conversely ERp44b.Tail (Fig. 3 .11- green line) suppressed aggregation as 
effectively as human PDI (Fig. 3 .11-light blue line) . 
(,00 
fir" 011"1) 
Figure 3.11. ERp44.1Tail showed chaperone-like activity 
Time courses of light-scattering changes roduced by the aggregation of 
denatured rhodanese 90 ~M du ring refolding u pon dilution (dilution 1 :20 
in phosphate buffer) in absence (black) and presence of ERp44 wt (red), 
ERp44 Tail (green), ERp44T369A (dark blues) or PDI (light blue), as 
indicated. ERp44 and PDI were added to rhodanese at molar ratio of 8. 
Then, we compar d the binding ability of ERp44 wt and ERp446Tail to 
int ract with Ero1a in a pull-down assay. As showed in Figure 3.12 
(compare lan s 1 to 3), ERp446Tail bound to Ero1a more efficiently than 
ERp44 wt. Th s data indicated that in vitro the removal of C-tail 
nhanc d binding and chaperone-like activity of ERp44 suggesting a role 
of - ail in r gulating Substrate Binding Site (SBS) accessibility. 
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..... GST-Ero 
I ERp44 
1 2 3 4 5 6 7 B 9 10 11 1213 
Figure 3.12. Interaction between ERp44 mutants and Ero in vitro 
Pull-down assay of ERp44 proteins. Glutathiol sepharose 4 fast flow 
beads were incubated at 25°C, pH 7 .5 for 1 h with 10-6 M GST-Ero1 a and 
various ERp44 proteins as indicated. Pull-down proteins and input (5% of 
the total protein used in the pull-down assay) were analyzed by SDS-page 
under reducing condition. Similar results were obtained in two 
independent experiments. 
To characterize in living cell ERp44 deletion mutant (Fig. 3.13), we 
transiently transfected different mammalian cell lines (HeLa, CHO, HepG2) 
with ERp44 wt or ~Tail. The binding activity of ERp44 was then assessed 
in SDS-page non-reducing conditions and in IP assays. Figure 3 .14 shows 
that ERp44~Tail displayed an enhanced disulfide-mediated activity 
towards endogenous proteins respect to wt protein (HMWC- compare lanes 
6 to 7). 
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6. Tail I a l __ b b' I RDEl ~ 
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6. Tail6.RDEL I a b b' 
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6p16 I a b b' v' RDEl V 
325 350 
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T369A 
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T369C b' l 
wt-GFP a b b' 1* ~ : GFP IKDEl 
T369C 
T369C-GFP a b b' I: !~ GFP IKDEl 
Figure 3.13. ERp44 proteins for mammalian expression 
Schematic representation of ERp44 cloned in pCDNA 3.1 vector for 
mammalian expression. Black square at N-terminus represents HA tag. 
Black circles are point mutations. 
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W8: 
~HA 
2 3 4 
R 
5 6 7 8 
NR 
/ 1369A 
ail 
Figure 3.14. The C-tail deletion (ERp44~Tail) and replacement 
(ERp44T369A) mutants accumulate intracellularly mostly as mixed 
disulfides with client proteins. Lysates from HeLa cells transiently 
tra n sfected with the indicated vectors (HA-tag ERp44) were prepared 48 
h after transfection and resolved by SDS-page under reducing (R) (lanes 
1-4) or non-reducing (NR) (lanes 5-8) conditions, blotted and decorated 
with monoclonal anti-HA antibodies . Tail mutants display an enhan ced 
disulphide-media ted activity respect to wt protein (ratio be tween 
monomer and HMWC). Asterisks mark anti-HA reactive background 
ba nds, present also in mock-transfected cells. White lines separate la nes 
2-3 and 6-7 , which were juxtaposed from the same gel. HMWC: high 
molecula r weight complexes. 
Consistently, IP assays showed that ERp44L'1Tail bound to Erola and IgM 
subunits more strongly than ERp44 wt (Fig. 3.15a- compare lanes 6 to 7 
and Fig. 3.15b- compare lanes 3 t04, respectively). To assess whether the 
removal of C-tail enhances the overall binding activity of ERp44 
independently from Cys29, we tested the interaction with non-covalent 
partner ERGIC-53. IP assay in Figure 3.15c showed that LlTail interacted 
to ERGIC-53 as much as wt protein. These data indicated that in living 
cells th removal of the C-tail greatly enhanced the binding properties of 
ERp44. 
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Figure 3.1Sa. Deletion of the C-tail does not alter ERp44 binding 
specificities 
H La c lIs trans~ ct d so as to co-express ERp44, ERp44[)Tail or 
ERp44T369A and Ero1a (A), 1l[)CH1 (B) or ERGIC-53 (C) were lysated and 
immunoprecipitat d with anti-HA antibodies. After washing, 
immunopr cipitat s were resolved by SDS-page under reducing 
condition, trans~ rr d to nitrocellulose and decorated with suitable 
antibodies to r veal associations (Anelli et al., 2002)(Anelli et al., 2003) 
(An Hi al., 2007). 
A. Th xperim nt showed is representative of three similar ones. The 
immunopr cipitat s from the total lysates of 3*106 HeLa transfected as 
indicated, w re wash d thoroughly and resolved by SDS-page under 
r du ing onditions. Blots were hybridized with anti-Myc to reveal co-
immunopr cipi t d Ero1a, or with anti-HA antibodies to follow 
xog nou ERp44. Lan s 9 - 11 (input) showed an aliquot of the lysates 
(105 11) b for immunopr cipitation, to monitor the expression levels in 
th diff r nt trans~ ctants. Ast risk mark anti-HA reactive background 
d . Th ffi i ncy of co-immunopr cipitation was determined by 
y of the Ero la and ERp44 bands of three 
p nd nt xp rim nt (s graph below). The graph is densitometric 
pI tting th r tio b tw en ERp44 and Ero1a (normalization: 
- r 1 int r tion i arbitrarily normalized to 1). The higher is 
± EM), th mor effective ERp44 is to interact with Erol. 
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Figure 3.ISb. Deletion of the C-tail does not alter ERp44 binding 
specificities 
B. The exp riment showed was performed according to a protocol similar 
to the on described in panel A, using HeLa transfectants expressing 
ERp44 variants and a known su bstrate, Ig-).illCH1 chains (Anelli et al., 
2003)(An lli tal., 2007). Blots were hybridized with anti-11 and anti-HA 
antibodi . Th band indicated with an asterisk consists of the heavy 
chain of th anti-HA antibody used for immunoprecipitation, that is 
r cogniz d by the secondary antibody used for detection. The efficiency 
of co-immunopr cipitation was determined by densitometric analyses of 
th f..l CH1 nd ERp44 bands of three independent experiments (see 
graph blow) . Th graph is densitometric analysis plotting the ratio 
b twe n ERp44 and J.l CH 1 (normalization: ERp44wt-)l~CH 1 interaction 
i arbitr ily normaliz d to 1). The higher is the bar (mean ± SEM), the 
mor ff ctiv ERp44 i to interact with Ero1u. As described for Ero1u, 
mor 11 H 1 h in ar co-precipitated by the tail mutants than by wild-
E p44. 
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Figure 3.1Sc. Deletion of the C-tail does not alter ERp44 binding 
specificities 
C. After cross-linking with DSP, a step that increases the efficiency of 
ERGIC-53jERp44 co-precipitation (Anelli et al., 2007), the lysates from 
H La c 11 transfected as indicated were immunoprecipitated with anti-
HA, and blots d corated with anti-ERGIC-53 or anti-HA antibodies. 
Taking into account the different expression levels of wt ERp44 and 
ERp446Tail ( T), th results clearly indicate that similar amounts of 
ERGIC-53 ( ither endogenous or myc-tagged, glycosylated overexpressed 
mol cuI , An Hi et a l., 2007) are co-precipitated, in line with the 
a umption that the association between the two proteins does not involve 
th ir ubstrat -binding domains and Cys29 (AneHi et al., 2007) . The 
gr ph i d n itometric analysis plotting the ratio between ERp44 and 
ER I -53 (normalization: ERp44wt-ERGIC-53 interaction is arbitrarily 
norm liz d to 1). 
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To exclude a possible gain of function non-related to its normal physiology 
due to the removal of 52 residues from ERp44, we checked whether the 
removal of C-tail affects, in living cells the stability of the deletion protein. 
In Figure 3.16a, HeLa cells expressing ERp44 wt or ~Tail were treated with 
CHX (protein synthesis inhibitor), to monitor the stability of proteins in a 
time-course. Generally, the intensity of short-lived molecules (i.e. Ik-Ba, 
orphan Ig subunits) decreased significantly in similar assays (Mancini et 
al., 2000) (Cenci et al., 2006) (our unpublished results). 
Densitometric analysis of SDS-page (Fig. 3.16a) shows that wt and 
deletion protein have similar stability. Then, we tested the solubility of 
ERp44 in a mild NP-40 buffer (Fig. 3.16b). Neither ERp44 nor the 
ERp44l\Tail mutants are detectable in the insoluble fraction when over-
expressed in HeLa cells. We can conclude that, although in E.coli the 
protein is partially insoluble (see part 3.1) likely due to hydrophobic 
pockets accessible to the solvent that could result in aggregation, in living 
cells it showed similar stability and detergent solubility excluding gross 
structural alterations (Fig. 3.16). 
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Figure 3.16. Deletion of the C-tail does not cause gross misfolding 
ofERp44. 
A. Stability. HeLa cells expressing ERp44 or ERp44~Tail were treated 
with cycloheximide (CHX) for 1, 2 or 4 h as indicated at 48 h after 
transfection. Aliquots of cell lysates were resolved under reducing 
conditions in SDS-page, blotted and decorated with monoc1onal anti-HA 
and a-actin antibodies (left panels). The intensity of the ERp44 bands 
was determined by densitometry and normalized against actin. 
Asterisks mark anti-HA reactive background bands. The plot in the right 
panel shows the percentage of ERp44 remaining in cells after 4 h of 
CHX treatment. 
B. Detergent solubility. HeLa cells expressing ERp44 or ERp44~Tail 
were lysed in NP-40 (upper two panels) or SDS (lower panel) at 48 h 
after transfection. NP-40 soluble and insoluble fractions were separated 
by centrifugation, and aliquots corresponding to the same number of 
cells resolv d by SDS-page, blotted and decorated with anti-HA 
antibody. Asterisks mark anti-HA reactive background bands. 
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As described in part 3.2, Cys29 sulphydryl forms hydrogen bonds with the 
hydroxyl of Thr369 in the C-tail. To gain more insights into a regulatory 
role of the C-tail we generated two point mutations, Thr369Cys and 
Thr369Ala that should reinforce and destabilize, respectively, the 
interaction between C-tail and domain a. According to our predictions 
ERp44-T369A should have an enhanced binding activity while T369C 
mutation should dampen. Confirming our predictions, ERp44-T369C 
showed an impaired binding to Ero la in vitro (Fig. 3.12- compare lanes 1 
to 4). Pre-treatment with dithiothreitol (reducing agent) partly restored 
binding, suggesting that an intramolecular bond is formed between Cys 29 
and Cys 369 that locks the C-tail (confirmed by mass spec. analysis; not-
showed), impedes substrate binding (Fig. 3.12- compare lanes 2 to 5). By 
contrast, ERp44-T369A, unable to form a hydrogen bond with Cys 29, 
bound to Ero1a more efficiently, which is in line with an increased 
accessibility of the -CRFS- motif and the hydrophobic surfaces (Fig. 3.12-
compare lane 1 to 6). 
To confirm in vitro data, we expressed ERp44-T369A in mammalian cell 
lines. Replacing Thr369 by alanine increased significantly the fraction of 
ERp44 that forms mixed disulphides with endogenous proteins in HeLa 
cells (Fig. 3.14-compare lanes 6 to 8) respect to wt protein. Moreover, IP 
assay (Fig. 3.15) showed that ERp44-T369A interacted with Ero1ci and 
with IgM subunits (Fig. 3.15a and b, respectively) more strongly than wt 
protein. 
This data demonstrated the interactions between C-tail and domain a 
(ERp44 T369A-destabilization; ERp44 T369C strengthening) could 
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modulate the binding properties of ERp44 suggesting a role of C-tail in 
regulating SBS accessibility during protein quality control in the Early 
Secretory Compartments (ESC). 
We investigated the mechanism allowing ERp44 to expose its binding sites 
for its physiological function by means of molecular dynamics (MD) 
simulations, a well suited approach to appreciate the dynamic behaviour 
of macromolecules (Karplus & Kuriyan 2005) (Rueda et aI., 2007). 
Monitoring the conformations of ERp44 under constant pressure and 
temperature for 10 ns (sampling of the NPT ensemble) for the wild type 
ERp44 protein revealed a stable, compact clover structure (Fig. 3.17- wt). 
A principal component analysis of the trajectory highlighted a propensity 
of the individual TRX-like domains to undergo rigid-body rotational 
movements. The C-tail of ERp44 apparently acts as a "molecular glue", 
forcing a- and b'- domains to undergo correlated motions. The interactions 
between strands (33 and p 16, the hydrogen bonds between Arg367 and 
residues of the (35-a4 loop, and the side chain interactions between 
Thr369 and Cys29 do not allow an "opening" of the C-tail (at least in the 
used time scale). Hence, we explored whether the removal of the last 9 
residues of ERp44 (including (316 strand) could de stabilize the interface, 
and facilitate the opening of the ERp44 C-tail (hereafter the mutant is 
named ERp4411P 16). Indeed, after 10 ns of NPT MD simulation the 
ERp4411(316 mutant undergoes a significant structural rearrangement (Fig. 
3.17- 11(316). Domain a partially reorients independently of b'-, and helix 
a2 (in purple) bearing the active site residue Cys29 assumes a regular, 
straightened conformation to fully expose the thiol to the solvent (Fig. 
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3.17). This conformation is suggestive of a highly reactive sulphydryl, and 
may thus represent an active conformation of ERp44. 
domain b domain b 
domain a 
domain a 
domain b domain b 
t 6,816 
Figure 3.17. ERp44~~16 mutant under oes a significant structural 
rearrangement 
Final structures of ERp44 wt and ERp44 ~~ 16 after .10 ns of NPT MD 
simulation. Th secondary structure cartoons are included inside 
transparent surface representations of ERp44 wt and ERp44L1~ 16 
mutant. The latter undergoes a significant structural rearrangement 
resp ct to wild type protein: domain a partially reorients independently 
of b l , and h lix a2 (in pink) bearing the active site residue Cys29 (orange 
sphere) ssumes a regular, straightened conformation to fully exposes 
th thiol to th solvent. Pictures for cartoons and surfaces, were 
gen r t d with Pymol. 
W t st d th ffect of the expression of ERp44~~ 16 mutant (-RDEL motif 
is maintain d) in H La cells . Compared to the wild type protein (Fig. 3.18-
compar 1 n s 7 to 9), in SDS-page non-reducing conditions this mutant 
displ ubstantially higher tendency to intermolecular disulfide bond 
form ti n including homodimerization yielding a Tail-like phenotype 
(Fig. 3. - omp r lan s 9 to 10). The removal of the last 9 residues of 
ERp 4 nh s th disulfide-mediated activity similarly to the full 
fth -t '1, xpect d from the conformations sampled in the 
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MD simulation. Moreover, the results hint at a primary role of the domain 
a a s a primary binding site for client proteins. 
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Figure 3.18. Removal of the last 9 residues of ERp44 enhances the 
disulfide-mediated activity towards endogenous client proteins in 
living HeLa cells. Lysates from HeLa cells, transiently transfected with 
HA-ERp44 wt, HA-ERp446~ 16, HA-ERp446Tail, ERp44R98Q or empty 
vector as indicated, were resolved by SDS-page reducing (R) non-reducing 
conditions (NR), blotted and decorated with monoclonal anti HA 
antibodies. Tail mutants display an enhanced disulphide-mediated 
activity respect to wt protein (ratio between monomer and HMWC). R98Q 
mutant accumulates as homodimers. The lane between 6 and 7 
represents the molecular weight marker. Asterisks mark anti-HA reactive 
background bands, present also in mock-transfected cells. HMWC: High 
Molecular Weight Complexes. 
3.3.2 -RDEL motif availability in ERp44 
Most soluble ER proteins (chaperones and folding enzymes) contain ER-
retrieval motifs at the C-terminus that are recognized by KDEL-Receptor 
(KDEL-R) implying that the motif should be exposed to the solvent, and 
thus accessible for the interaction with its receptor. Indeed, the -KDEL 
motif is not visible in the crystal structure of ER resident protein 
presumably due to high flexibility (ERp44 in Fig. 3.9) (yPDI-Tian et aI. , 
2006) (ERp29-Barak et aI., 2009). Nevertheless, in the crystal structure of 
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ERp44 the "closed" conformation of the C-taillikely positions -RDEL motif 
very close to domain a and so may partially hinders its availability to 
KDEL-R. In order to investigate whether the C-tail rearrangements are 
propaedeutic for proper ER-retrieval, we took advantage of Thr369Cys 
mutant in living cells. In part 3.3.1 we showed that T369C mutant has an 
impaired binding of Ero la in pull down assays, indicating that the 
intramolecular disulfide bond between Cys29 and Cys369 impedes 
substrate binding. 
In HeLa cells, wild type HA-ERp44 over-expressed is almost exclusively 
intracellular as expected (Fig. 3.19a- lanes 2 and 6), while the over-
expressed HA-ERp44-T369C mutant is completely secreted in the culture 
medium, to levels comparable with overexpressed HA-ERp44~RDEL that 
lacks the ER retrieval signal (Fig. 3.19a- compare lanes 7 to 8). However, 
endogenous ERp44 is fully retained intracellularly (faster migrating bands 
in lanes 1-4) indicating that KDEL-R is not saturated by the over-
expression of HA-ERp44. These data suggest that the "closed" 
conformation of the C-tail may hamper KDEL-R recognition of the ERp44 
C-terminal motif. Alternatively, it may suggest a requirement for 
interaction of ERp44 with its substrates for its retrieval in the ER. 
In accordance to the first hypothesis, a chimerical molecule ERp44-
T369C-GFP-KDEL (Fig. 3.13), in which a GFP has been placed between 
the end of the C-tail and the -KDEL sequence (providing a sort of "spacer" 
for fully expose -KDEL motit) , is partially intracellularly retained (Fig. 
3. 19b-Ianes 3 and 5). 
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Figure 3.19a and h. ERp44 T369C is fully secreted in living HeLa 
cells. 
A. Lysates (c) from HeLa cells, transiently transfected with HA-ERp44 
(wt), HA-ERp446RDEL (6RDEL), HA-ERp44-T369C (T369C) or empty 
vector as indicated were resolved by SDS-page under reducing (Red) or 
non-reducing (NRed) , conditions, blotted and decorated with monoc1onal 
anti ERp44. The culture supernants (SN) of 16h were precipitated with 
TCA and then resolved under reducing condition (Red) or IP with a-HA 
antibodies and then resolved under non-reducing conditions (NRed), as 
indicated. The band indicated with an asterisk consists of the heavy chain 
of the anti-HA antibody used for immunoprecipitation, that is recognized 
by the secondary antibody used for detection. 
B. Lysates (c) from HeLa cells, transienpy transfected with ERp44-GFP-
KDEL (wt-GFP), ERp44-T369C-GFP-KDEL (T369C-GFP) or empty vector 
as indicated were resolved by SDS-page under reducing (Red)conditions , 
blotted and decorated with monoc1onal anti GFP. The culture supernants 
(SN) were precipitated with TCA and then resolved under reducing 
condition (Red). Asterisks mark anti-GFP reactive background bands, 
present also in mock-transfected cells. The doublet present in ERp44-GFP 
could represent a post-translational modification that occurs in the 
chimera. 
The SDS-page non-reducing conditions in Figure 3.19c shows that 
intracellular ERp44-GFP-KDEL displays a disulphide-mediated activity 
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with endogenous proteins while intracellular ERp44-T369C-GFP-KDEL 
seems do not form mixed disulfide with endogenous proteins (see HMWC 
in la n es 5 and 6). This observation suggests that, also in living cells, the 
Cys29 -Cys369 disulfide bond locks the C-tail de facto hampering 
substra te binding. 
Altogether, These results indicate that a restriction of the C-tail 
rearrangements (the intra-molecular disulphide bond Cys29-Thr369 locks 
the C-tail- see Fig. 3.12) impairs the proper retrieval of ERp44 most likely 
due to less efficient recognition of -RDEL motif of ERp44. A partial 
recovery of the ESC retrieval is observed when a spacer (GFP) is provided 
to ERp44 to increase the exposure of -RDEL motif 
c 
WB: 
OI-GFP 
Red NRed 
HMWC 
1369C-GFP 
wt-GFP 
Figure 3.19c. ERp44 T369C is fully secreted in living HeLa cells. 
Lysa tes from HeLa cells, transiently transfected with ERp44-GFP-KDEL 
(wt-GFP-KDEL), ERp44-T369C-GFP-KDEL (T369C-GFP) or empty vector 
as indicated were resolved by SDS-page under reducing (Red)or non-
reducing conditions (NRed), blotted and decorated with monoc1onal anti 
GFP. The limited shift of molecular weight of T369C-GFP in non-reducing 
SDS-page respect to wt-GFP in Fig. 3.19c (compare lanes 5 to 6) is 
suggestive of Cys29-Cys369 bond rather than being a covalent mixed 
disulphide. The same shift is present in HA-ERp44-T369C in Fig. 3.19a in 
comparison with HA-ERp44 (non-reducing panel lanes 7 to 8). Faster 
migrating bands may represent protein degradation of GFP chimeras. 
Asterisks mark background bands. HMWC: High Molecular Weight 
Complexes. 
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3.4 ERp44 regulation in living cells 
3.4.1 ESC pH gradient regulates ERp44 activity 
To investigate the mechanisms regulate that C-tail rearrangements, we 
focused our attention on the pH gradient along the ESC. Indeed, the 
luminal pH IS not homogeneous throughout the secretory pathway 
(Paroutis et al., 2004) whereas the pH of the endoplasmic reticulum is 
near neutral, similar to that of the cytosol, downstream compartments 
become progressively more acidic. The eis-Golgi complex is significantly 
more acidic (pH - 6.7) than the ER and the acidification becomes more 
marked in subsequent cisternae of the Golgi complex, reaching pH - 6.0 
in the trans-Golgi network (Paroutis et al., 2004). 
The regulation of the pH of the organelles of the ESC is critical for the 
trafficking, processing, and glycosylation of secretory proteins. According 
to our model (Fig. 4.1), the pH gradient along ESC might control ERp44 
activity, which should capture its client proteins in the Golgi complex and 
release them in the ER. Supporting evidence comes from the observation 
that ERp44-IP3R1 interaction is pH-, redox state-, and ER Ca2+-
dependent (Higo et al., 2005). 
Ammonium chloride treatment is widely exploited to raise the ESC 
luminal pH in living cells (Axelsson et aI., 2001) (Appenzeller-Herzog et aI., 
2004) (Maeda et al., 2008). According to our model (Fig. 4.1), a 
neutralisation of the pH gradient along the ESC should dampen thiol-
mediated retention of ERp44. 
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Our data indicate that treatment with ammonium chloride results in an 
increased formation of homodimers and covalent complexes with natural 
substrates in overexpressed wt protein compared to physiological 
conditions (Fig.3.20- compare lanes 6 to 8). 
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Figure 3.20. Ammonium chloride treatment induces ERp44 
homodimerization. 
Lysates from HeLa cells, transiently transfected with HA-ERp44 wt or 
with an empty vector as indicated, were resolved by SDS-page under 
reducing (R) non-reducing (NR) conditions, blotted and decorated with 
anti-HA antibodies. The arrows indicate ERp44 homodimer, which is 
induced after NH4Cl treatment (ratio dimer / monomer increases upon 
NH4Cl treatment). Similar results were obtained in 3 independent 
experiments. Asterisks mark anti-HA reactive background bands, 
present also in mock-transfected cells . 
The pH sensitivity of ERp44 activity was assessed in functional assays 
exploiting our well-established assay for TMR activity in which 
overexpressed ERp44 retains overexpressed Ero 1 a (Anelli et al.) 
2003)(Otsu et al., 2006). 
As showed in Figure 3.21a (and in the densitometric analysis graph in Fig. 
3 .22), ERp44-mediated Erola retention is weakened by NH4Cl treatments 
in HeLa cell lines (Fig. 3.21a- compare lanes 7 to 8) (confirmed a lso in 
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CHO cell lines; not-showed). Thus, more Ero1a accumulates 
extracellularly, whilst the secretion of a1AT (Fig. 3.21c), a protein that 
does not bind ERp44 (not-showed), is inhibited by NH4CI (Fig. 3.21c-
compare lanes 7 to 8) (a condition known to perturb glycan processing 
and secretion reported in Axelson et aI., 2001 and in Maeda et aI., 2008; 
Ero 1 secreted is present as a doublet likely due to a partial inhibition of 
glycosylation processes beyond ER). 
SN WB: 
+ + 
Oc- Myc 
OI- HA 
5 6 7 8 
Ero1 Ero1 +p44 
Figure 3.21a. Role of pH on ERp44-mediated Erola retention 
A. As predicted by our model NH4CI treatment makes ERp44 less active in 
retaining Ero1a. Supernatants after 4 h of culture in Optimem (SN) and 
celllysates (cell) from HeLa cells transfected with Myc-Ero1 alone or Myc-
Ero1 + HA-ERp44 wt (p44) as indicated, were analyzed by Western 
blotting with monoclonal antibodies against Myc (Ero1a) or HA (ERp44). 
When over-expressed, Ero1a is partially secreted (lane 5). The over-
expression of ERp44 drastically reduced secretion (compare lanes 5 with 
7). ERp44-mediated retention is weakened by NH4CI treatment (compare 
lanes 7 with 8). The appearance of secreted Ero1a bands with different 
mobility reflects altered glycan processing in NH4CI-treated cells (Maeda et 
aI., 2008). See Fig. 3.22 for the densitometric quantification of 10-22 
experiments performed like the one showed in SDS-page, plotting the ratio 
between intracellular (IN) and secreted (OUT) Ero1a. 
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Figure 3.21b and c. Role of pH on ERp44-mediated Erola retention 
B. Supernatants (after 4 h of culture in Optimem) and cell lysates from 
HeLa transfected with Erola-Myc alone or Erola-Myc + PDI as indicated, 
were analyzed by Western blotting with monoclonal antibodies against 
Myc (Erola). 
The over-expression of PDI drastically reduced secretion (compare lanes 5 
with 7). PDI-mediated retention is little affected by NH4CI treatment 
respect to ERp44 (compare lanes 7 with 8). See Fig. 3.22 for densitometric 
quantification of 5 experiments performed like the one showed in SDS-
page, plotting the ratio between intracellular (IN) and secreted (OUT) 
Erola. The higher is the bar, the more effective PDI is to retain Erola . 
C. Supernatants (after 4 h of culture in Optimem) and cell lysates from 
HeLa cells transfected with alAT or alAT + HA-ERp44 as indicated, were 
analyzed by SDS-page, blotted and decorated with anti aATl mono clonal 
antibody. When over-expressed, alAT, a protein which is not known to be 
an interactor of ERp44, is fully secreted (lane 5). The secretion of alAT is 
inhibited by NH4CI (compares lane 5 with lane 6 and 7 with 8). 
Considering that NH4CI inhibits secretion of a lAT and Ero 1 expressed in 
the same cells, owing to a general effect on processing and secretion 
(Maeda et al., 2008), the effects of pH on ERp44-mediated Erola secretion 
ar more marked. 
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Considering a less efficient secretory pathway, the inhibitory effects of 
NH4CI on ERp44-mediated Ero1a retention are even more marked. When 
PDI was used to prevent Ero1a secretion (Otsu et al., 2006) (Fraldi et aI., 
2008), NH4CI had little effects, further confirming the specificity of pH 
disregulation (Fig. 3.21 band densitometric analysis graph in Fig. 3.22). 
ERp44-mediated Ero1a. retention 
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Figure 3.22 ERp44-mediated Erola retention 
untreated 
• ammonium chloride 
trea ed 
Plot is d nsitometric analysis of Fig. 3.21a and b and Fig. 3.24 of 5-22 
xp rim nts p rformed like the ones showed in SDS-page in the 
figur , plotting th ratio between intracellular (IN) and secreted (OUT) 
Ero 1 a . Th higher is the bar (mean ± SEM), the more effective ERp44 
is to r ain Erola. Asterisk: two tailed T-test, *p<0.05. Plus: one-way 
AN VA with Bonferroni's post tests, +p<O.O 1. Differences were 
con id r d ignificant at p < 0.05. 
Fig. 3.2 1:NH Cl tr atm nt weakens the TMR activity of ERp44 but has 
littl f£ t on PO!. 
Fi . 3. 25 : ERp44 Hi displayed an enhanced TMR activity respect to wt 
pr m hil ERp44 T il and ERp44.1P 16 were partially inhibited. 
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NH4CI treatment does not grossly affect the localization of overexpressed 
HA-ERp44, which accumulated primarily in ER (IF in Fig. 3.26a). 
Moreover, NH4Cl treatment seems that does not affect KDEL-R activity 
since ERp44 was not detected in the medium (non-showed). 
Given the known pH differences in the ESC organelles, these results may 
be indicative of a physiological mechanism that regulates ERp44 in vivo. 
3.4.2 pH sensor in ERp44 
In order to identify in ERp44 possible "pH sensor", we took advantage of a 
panel of structure-based designed mutants (Fig. 3.13). 
We noticed that residue Arg367 of the C-tail is involved In hydrogen 
bonding interactions with the backbone of the loop connecting strand p5 
to helix u4, and has its side chain guanidinium stacked above the same 
group of residue Arg98. Both semi-empirical and quantomechanical 
analyses suggested a shift of the pKa of Arg98 towards lower values, 
making this residue pair a candidate as a pH sensor in the different 
compartments of the ESC. 
To test the role of these residues in pH mediated activity of ERp44 we 
replaced Arg98 with a GIn (mimicking the deprotonated state) yielding 
ERp44 R98Q. In agreement with our prediction, Arg98Gln mutation 
seemed to partially dampen TMR activity of ERp44 (Fig. 3.25- compare 
lanes 10 to 13). Owing to partial inhibition of this activity, ERp44 R98Q is 
less affected by NH4CI treatment respect to wt protein (densitometric 
analysis Fig. 3.22). The partial inhibition of TMR activity is also confirmed 
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by IP assay in wh ich ERp44 R98Q interacted to less extent to 
Ero1a compared to wt protein (Fig 3.23- compare lanes 4 to 6) 
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Figure 3.23. Interaction between Erola and ERp44 mutants 
H La c 11 w r transfected with the indicated p lasmids , Cell lysates 
w r immunopr cipitat d (IP) with a-Myc sepharose beads, and then 
r solv d b D -pag , b lotted and decorated with anti-HA (ERp44) and 
ti-M c (Ero1 a ) antibodies, as indicated. The efficiency of co-
immunopr cipi tion was determined by densitometric analyses of the 
Ero 1 d ERp44 b nds of four independent experiments (see graph 
blow). Th gr ph i d nsitometric analysis plotting the ratio between 
ERp44 d Ero la (normalization: ERp44wt-Ero la interaction is 
bitr il norm iz d to 1) . The h igher is the bar (mean ± SEM), the 
ff tiv ERp44 i to int ract with Ero la. Note that the tail ERp44 
in , 
mor trongly with Erola than wild-type ERp44 does 
R 8Q mutants interact less with Ero 1 respect to wt 
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Peculiarly, in non-reducing SDS-page (Fig. 3.18- lanes 12) ERp44 R98Q 
accumulates mainly in covalent homodimeric species, enriched in NH4CI 
treated cell expressing ERp44 wt (Fig. 3.20). 
These results are highly suggestive of Arg98 as key residue in mediating 
pH sensitivity of ERp44. However, ERp44 R98Q conserved partially both 
TMR and binding activity suggesting that also other mechanisms 
contribute to regulate ERp44 activity. 
3.5 ERp44-substrate binding and release 
Most of (perhaps all) molecular chaperones should undergo a substrate 
binding/ release cycle. ERp44 is a chaperone of ESC that should bind 
client proteins in ERGIC and release in ER. 
In part 3.3 we reported that C-tail rearrangements of ERp44 are 
mandatory to expose Substrate Binding Site (SBS) and thus could play a 
role in regulating binding and release of client proteins. Moreover, in part 
3.4 we demonstrated that TMR activity of ERp44 is regulated by ESC pH 
gradient. To further analyze the role of C-tail in chaperone properties of 
ERp44 we took advantage of a panel of structure-based mutants. 
Moreover, we showed that ERp44~P 16 displayed an enhanced disulfide-
mediated activity of ERp44 (Fig. 3.18). Consistently, Figure 3.23 shows 
that in IP assay ERp44~P 16 displayed an enhanced binding activity 
towards Ero la in HeLa cells respect to wt protein (Fig. 3.23- compare 
lanes 4 to 8 and its densitometric analysis below). 
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In order to identify other "hot spot" for ERp44 binding/release cycle, we 
removed a conserved His loop (yielding ERp44~His- Fig. 3.13) in the C-tail, 
invisible in the crystal structure likely due to its flexibility (see part 3.2 
and Fig. 3.9). Often disordered regions in protein serve as docking site for 
ligand partners, and undergo a structural rearrangement upon complex 
formation (Luan et aI., 2000) (Fink 2005)(Dierks et aI., 2005). 
We tested the effect of the expreSSlOn of ERp44~His in HeLa cells. 
Compared to the wild type protein, ERp44~His displayed clearly lower 
tendency to intermolecular disulfide bond formation towards endogenous 
protein (Fig. 3.24). 
WB: 
OI-HA 
* 
* 
* 
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+-- ERp44 vvt 
+-- ERp44 LlHis 
Figure 3.24. The removal of the His-loop diminishes the disulfide-
mediated activity of ERp44-
Lysates from HeLa cells transiently transfected with HA-ERp44 wt, 
ERp44 His or empty vector were resolved by non-reducing conditions 
(NRed), blotted and decorated with monoclonal anti HA antibodies. Note 
that ERp44 His displays a reduces disulphide-mediated activity respect 
to wt protein (ratio between monomer and HMWC). Asterisks mark anti-
HA reactive background bands, present also in mock-transfected cells. 
HMWC:High Molecular Weight Complexes. 
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Consistently, the removal of the His loop, although remote from SBS in 
domain a, dampens the binding activity of ERp44 to Ero molecules (IP 
assay; Fig. 3.23- compare lanes 4 to 5 and densitometric analysis below). 
These data suggested that C-tail contributes to regulating the binding 
properties of ERp44 where the removal of ~ 16 and His-loop make the 
protein, hyper-reactive and hypo-reactive, respectively. 
W8: 
Ot-Myc 
Ot-HA 
HA-ERp44 
cell 
123 4 567 
*~~)..,~ ;-~O~~lb 
Myc·Eroex 
SN 
8 9 10 11 1213 14 
Myc·Eroex 
Figure 3.25. Role of C-tail on ERp44-mediated Erola retention 
Supernatants after 4 h of culture in Optimem (SN) and cell lysates (cell) 
from HeLa cells transfected with Erola- Myc alone or Erola-Myc + HA-
ERp44 mutants as indicated, were analyzed by Western blotting with 
monoc1onal antibodies against Myc (Ero1a) or HA (ERp44) . When over-
expressed, Ero1a is partially secreted (lane 9). The over-expression of 
ERp44 reduces secretion to different extents (compare lanes 10- 14). See 
Fig. 3.22 for the densitometric quantification of 4 to 14 experiments 
performed like the one showed in SDS-page, plotting the ratio between 
intracellular (IN) and secreted (OUT) Ero la. 
Th n , w assessed the TMR activity of ERp44L1~16 and ERp44L1His 
mutant in w ll-established functional assays in which over-expressed 
ERp44 retains over- xpressed Ero1a (see part 3.4; Anelli et al., 2003; Otsu 
a l. , 2006). 
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ERp44-mediated Erola retention assay showed that, although hypo-
reactive, ERp44~His displayed a substantially higher activity in Erola 
retention than wt (SDS-page in Fig. 3.25 and densitometric analysis in 
Fig. 3.22). Consistently with our model in Fig. 4.1, also Ero la retention 
activity of ERp44~His is weakened by NH4CI treatment (Fig. 3.22). 
TMR activity of two hyper-reactive mutants, ERp44~P 16 and ERp44~Tail 
seemed to be partially crippled (SDS-page in Fig 3.25 and densitometric 
analysis in Fig. 3.22). 
Based on these preliminary data of binding and TMR activity we could 
propose a kinetic model in which different region of C-tail contribute to 
regulate the cycle of binding/release of ERp44: according to our working 
model the binding is inversely correlated to TMR activity. 
ERp44 should bind its substrates in ERGIC and release in ER, thereby 
trafficking along ESC should be well-regulated to support ESC folding 
demand. We have previously showed that ERGIC-53 contributes to dictate 
the ERGIC-Iocalization of endogenous ERp44 (Anelli et aI., 2007). 
Although over-expressed ERp44 wt localized mainly in the ER (Anelli et 
aI., 2002), conserved TMR activity (Anelli et aI., 2003) (Otsu et aI., 2006) 
(Anelli et aI., 2007) (Wang et aI., 2007) (Fraldi et aI., 2008) (Mariappan et 
aI., 2008) (Cortini and Sitia 2010). 
To study whether binding/release cycle (or at least the hyper-hypo 
reactivity of ERp44 mutants) is linked to localization/ trafficking of the 
protein, we proceeded to the characterization of hyper-reactive and hypo-
reactive mutants. Similarly to over-expressed wt protein, hyper-reactive 
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ERp44~P 16 accumulates mainly III the ER at the steady state In fixed 
HeLa cells (Fig. 3.26a and 3 .26b). 
ERp4 wt 
+ H" 
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Figure 3.26a. ERp44.6.His does not accumulate primarily in the ER 
HeLa cells were cu ltured and transfected with HA-ERp44 wt, .6.~ 16 or .6.His 
as indicated on cover slips . 48 h after transfection, cells were treated with 
50 mM NH4CI where indicated. Cells were then fIxed in Methanol 100% for 
10 s. and after permeabilized in 0.1 % TX-I 00, stained with antibodies a -
HA and various organelles markers (Crt, ERGIC-53 or GM-130) as 
indicated. HA staining is in green, organelle marker staining in red. 
A. ERp44 wt localized mainly in the ER also after NH4CI treatment. 
b 
HA 
HA 
HA 
ERp44A816 
Crt 
ERGIC-53 
G -130 
merged 
merged 
merged 
Figure 3.26b. ERp44 His does not accumulate primarily in the ER 
H L 11 u ltur d nd transfected with HA-ERp44 wt, ~ 16 or His 
on ov r lips. 48 h after trans~ ction, cells were treated with 
I wh r indi at d. Cells wer then fixed in Methanol 100% for 
ft r p rm biliz d in 0 .1% TX-100, stained with antibodies a -
or n 11 markers (Crt, ERGIC-53 or GM- 130) as 
ining i in green, organ lIe marker staining in red. 
1 liz d m ·nly in th ER. 
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HA 
c 
d 
ERp4 ~Hls 
Ct1 merged 
Figure 3 .26c and d. ERp44~His does not accumulate primarily in 
the ER 
c. ERp44~His localized does not accumu late mainly in the ER. For 
panels c and i, boxes show a h igher magnification of the indicated area. 
Arrows indicate examples of co-localizing structures. 
D. Magnification of pan 1 a-Fig.A and panel a-Fig.C to compare the 
different distribu tion patterns of ERp44 wt to His. 
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When we removed -RDEL motif from ERp44 wt, the protein is completely 
secreted (Fig. 3.26-ERp44wt~RDEL). By contrast ERp44~Tail~RDEL 
(hyper-reactive mutants in which -RDEL motif was removed) is partially 
retained intracellularly (Fig. 3.27- compare lanes 3-4 to 7-8). These data 
suggested that, although co-localized with ERp44 wt, hyper-reactive 
mutant are partially impaired in its trafficking or at least in ER exit most 
likely due to high affinity for ER matrix. 
Conversely, ERp44~His mutant does not seem to accumulate primarily in 
ER, assuming a partial asymmetric perinuclear clustered distribution (Fig. 
3.25c and Fig 3.25d) overlapping the localization of endogenous ERp44 
(Anelli et aI., 2007) (Wang et aI., 2007). 
These preliminary characterization of ERp44 mutants hint at the tight 
relationship between kinetic cycle of binding/release (or alleast reactivity) 
a nd trafficking that might modulate TMR activity of ERp44. 
ERp44t.tail 
1 2 3 4 5 6 7 8 
C SN C SN C SN C SN 
wt -wt t.Tail t.Tail 
bRDEL bRDEL 
WB: 
ec-HA 
+- ERp44wt 
secreted 
Figure 3.27. ERp44~Tail~RDEL is partially retained intracellularly 
Supernatants after 16 h of culture in Optimem (SN) and cell lysates (C) 
from HeLa transfected with HA-ERp44 wt and mutants as indicated, 
were analyzed by western blotting with antibodies against HA (ERp44). 
ERp44 w~RDEL is fully secreted (lanes 3 and 4) while ~Tail~RDEL is 
partially retained intracellularly (lanes 7 and 8). Asterisk marks anti-HA 
reactive background bands. Secreted ERp44wt~RDEL and ~Tail~RDEL 
are slower migrating than intracellular ones likely due to post-
translational modifications (O-glycosylation) that take place beyond ER. 
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4. Discussion 
4.1 ERp44 C-taU rearrangements 
The function of many molecular chaperones depends on the regulation of 
the availability of Substrate Binding Site (SBS) by means of ATP-
dependent conformational changes. Since ERp44 does not show any ATP 
binding nor hydrolysis, its function should be mediated, at least, through 
the transient nature of the contacts between C-tail and TRX-like domain a 
containing SBS. We showed that the destabilization of the interactions 
between C-tail and domain a (ERp44-T369A and ERp44~JH6) and their 
strengthening (ERp44-T369C) modulated the binding activity of ERp44 
suggesting a role of C-tail in regulating the accessibility of SBS during 
protein quality control in the Early Secretory Compartments (ESC)(Fig. 
4.1). Indeed, MD simulations suggest that C-tail rearrangements (or at 
least the destruction of the interaction between p 16 in the C-tail and the 
TRX domain a) trigger a conformational change in domain a suggestive of 
a highly reactive sulphydryl, and thus it may represent an active 
conformation of ERp44. In addition, domain a rearranges independently 
from domain b'. 
The results hint at a primary role of the domain a as a primary binding 
site for client proteins although we could not exclude a "full" opening of 
the C-tail to expose also domain b' hydrophobic pocket providing an 
additional docking site to accommodate substrates. The inter-domain 
flexibility and the accessibility of SBS, both modulated by C-tail 
rearrangements seem to be the way whereby the ESC tunes ERp44 and 
thus, its protein quality control capacity. 
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The crystal structures of a prototype of PDI-family, yeast PDI (Tian et aI., 
2006) (Tian et aI., 2008) revealed similar mechanisms of regulation of SBS 
accessibility. The spatial arrangement of the four domains in the 
homodimer (Tian et aI., 2008) differed significantly from the structure 
reported for monomeric form (Tian et aI., 2006). Moreover, in the dimer, 
both the active site in a ' domain and the SBS in the b' domain are buried. 
This conformation of the dimer therefore presumably represents an 
"inactive" state of PDI, because most of its catalytic elements are 
inaccessible. On the other hand, monomeric state most likely represents 
an "active" form of PDI. The transition between monomeric and dimeric 
PDI could be a regulatory mechanism (Tian et aI., 2008). Very recently, 
Freedman and co-workers reported another conformational change in 
human PDI (Van dat Nguyen et aI., 2008) linked to SBS availability in 
domain b' very similar to conformational change describe in part 3.3 for 
ERp44. In both hPDI and yPDI, the b' domain is thought to be a primary 
SBS (Klappa et al., 1998)(Tian et al., 2006). Biophysical and NMR analysis 
revealed that the x region of PDI (see Fig. 1.6) can interact with the b ' 
domain by "capping" a hydrophobic site on the b ' domain. This site IS 
most likely the SBS and hence such capping will inhibit substrate 
binding. 
In addition to its role in modulating the accessibility of SBS of ERp44, the 
C-tail seems to be important for retrieval in the ESC. The "closed" 
conformation of the C-tail apparently could influence also the accessibility 
of -RDEL motif and therefore the interaction with its specific receptors 
(KDEL-R). Indeed, the retrieval of T369C mutant is partially rescued when 
a spacer (GFP) was employed to further protrude the -RDEL signal. An 
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intriguing possibility is that interaction with substrates exposes the -
RDEL motif for binding to KDEL-R and retrieval. 
Although retained intracellularly, ERp44-T369C-GFP does not form mixed 
disulfide with endogenous proteins suggesting that the Cys29-Cys369 
disulfide bond locks the C-tail, hampering substrate binding. This 
observation is consistent with ERp44 T369C pull-down in vitro assays 
which shows that the full reactivity is restored only after DTT treatment. 
Hence, ERp44-T369C-GFP may cycle in ESC without any covalent 
interaction with substrates. Alternatively, the Cys29-Cys369 bond may be 
initially undone and then rapidly re-formed due to the local higher molar 
concentration of the C-Tail with respect to the endogenous substrates, de 
facto competing each other for the accessibility of SBS. According to this 
hypothesis a competition between the C-tail and substrates for SBS may 
be part of the ERp44 mechanisms of action. 
Altogether, these data suggest that In living cells the C-tail 
re arrangements dynamically regulate both the reactivity of ERp44 with its 
endogenous client proteins, perhaps restricting its specific ity , and the 
availability of the C-terminal-RDEL motif to KDEL-R (Fig 4.1). 
It will be of interest to identify the mechanisms that control the ERp44 C-
tail movements (see part 4.3) 
4.2 ESe pH gradient-mediated regulation of ERp44 
Part of the project was devoted to examine how ERp44-mediated Ero 1 a 
retention is modulated by ESC pH gradient. Based on the available 
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evidence, we could draw a unifying model of the ERGIC-53/ERp44 
pathway, in which pH inversely controls the binding properties of ERGIC-
53 and ERp44 (Fig. 4.1). The former is known to capture cargoes in the ER 
and release them in the Golgi in a pH-dependent way (Hauri et aI., 2000) 
(Appenzeller-Herzog et aI., 2004). According to our model, ERp44 captures 
its substrates in the cisGolgi, whose lower pH may modulate C-tail 
rearrangement to expose both the SBS and the -RDEL sequence. The 
ensuing complex, KDEL-R/ERp44/cargo, could be efficiently retrieved to 
the ER where it dissociates because of the higher pH. 
The pH-mediated regulation of ERp44 may derive from disruption of the 
interface between domain a and the C-Tail, from interaction with other 
ligand partners, or a combination of both mechanisms. Indeed, the 
protonation of Arg98 in the ERGIC-cisGolgi complex might destabilize the 
interface between domain a and C-Tail through charge repulsion between 
the side chains of Arg98 and Arg367, thus favouring the C-tail 
rearrangements. In accordance with this hypothesis, the replacement of 
Arg with GIn partially inhibited both binding and TMR activity of the 
protein, likely because of the prevention of these interface-destabilizing 
repulsive interactions. ESC pH gradient may also regulate the 
protonation/ deprotonation of residues involved in other functional states' 
of ERp44 such as substrate binding/ release and homodimer formation. A 
non-mutually exclusive hypothesis could be that the protonation may also 
de stabilize the interface in the covalent homodimer. Indeed when we 
replaced Arg98 (located very close to Cys29 in domain a) with GIn, ERp44 
accumulates as homodimer. This species is also present in ERp44 wt 
although to lesser extent suggesting that the mutation may capture a 
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physiological state of the protein. We have previously proposed (Anelli et 
al., 2003) that covalent homodimer of ERp44 may represent an 
intermediate species between monomeric and cargo-bound state. Since 
ERp44 does not display any of activity oxidase nor reductase (Wang et al., 
2008), dimer form may itself provide oxidative power through disulfide 
exchange with substrates proteins and vice versa. 
Although little is known about residues involved in homodimerization, 
Arg98 seems to play a key role in favouring the formation of this species. 
In accordance with our hypothesis NH4CI treatment induce a slight 
homodimerization in ERp44 wt partially mimicking R98Q mutation. 
According to these data, the protonation of Arg98 may play a dual role in 
C-tail rearrangement and also in "homodimer regulation", de stabilizing the 
interface between domain a and C-tail and between two ERp44 molecules. 
These two molecular mechanisms could be indeed two steps of the same 
mechanism of ERp44 activation in which Arg98 is the master regulator. 
Other ATP-independent chaperones and folding helpers use ESC pH 
gradient to regulate their substrate binding and release. In RAP (receptor 
associated protein), an overall increase of the positive surface charge due 
to protonation of solvent-exposed histidine side chains in the Golgi 
complex support the dissociation of RAP chaperone from LPR (Iow-density 
lipoprotein receptor-related protein, member of the LDL receptor family-
Lee et aI., 2006). Histidine residues are part of interface between 
chaperone and substrate, and thus the histidine to alanine residue 
mutation impairs dissociation of RAP from LRP at lower pH. Similar 
studies (Appenzeller-Herzog et aI., 2004) reported that His178 residue is 
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the hallmark of molecular pH sensor in ERGIC-53. In this case, upon 
arrival in the ERGIC, His-178 in ERGIC-53 is protonated because of 
lowered luminal pH, leading to the loss of one (or more) Calcium ions. 
Thereby, lectin activity of ERGIC-53 is inactivated and thus triggers cargo 
release. In living cell, neutralization of pH gradient in the ESC leads to 
inhibition of the release of ERGIC-specific cargo (Appenzeller-Herzog et aI., 
2004). 
In these two cases histidine residues play a key role in binding/ release 
cycle of the protein and thus, ESC pH gradient affect primarily the 
interaction with substrates. 
Erola is the favourite substrate of ERp44 (Anelli et aI., 2002) and when 
over-expressed is abundantly secreted. The co-over-expression of ERp44 
fully retains intracellularly Erola. Moreover, Erola is not reported to be 
ERGIC-53 substrate (our unpublished data), a lectin inversely regulated 
by pH gradient (Appenzeller-Herzog et al., 2004). Being an ER resident 
protein, O-glycosylation and Golgi-glycan processing (both partially 
inhibited by NH4CI treatment) should not be important for its oxidative 
activity in ESC. IgM polymerization/ secretion could be severely affected by 
NH4Cl since they involve more complex quality control and processing 
machineries (Anelli et aI., 2007). Hence, Erola is bona fide a good 
candidate as ERp44 TMR-substrate for our studies. 
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Figure 4.1. A possible model of the regulatory role of the C-tail 
in modulating SBS accessibility along ESC 
The pH gradient between the ER and the Golgi complex (depicted as 
a shade of grey) could regulate ERp44 activity, by opening the C-tail 
(from orange-ERp44 to red-ERp44) simultaneously making the 
ERp44 SBS accessible to substrates (lgM subunits in grey, SUMFl 
in purple or Erol in light blued) and the C-terminal RDEL motif to 
KDEL-Receptors (in blue) . In the magnification panels, the cartoons 
depict clover-like structure of ERp44 where hydrophobic pockets 
(white) and the Cys29 (red ball) are shielded by the C-tail, yielding 
the close conformation (orange ERp44). Once the C-tail swings off to 
xpose the SBS (Cys29 and hydrophobic patch surrounding in 
domain a) (red ERp44), client proteins could then interact with 
ERp44. The C-tail rearrangements also increase the exposure of -
RDEL motif allowing the effective interaction with KDEL-R which in 
turn, retrieve via COPl vecicles the ERp44-cargo complex to the ER. 
Here, the C-tail swings onto the a domain, expelling the client 
prot in, switching ERp44 to a 1 ss-active state (orang ERp44) 
At th lower pH active ERp44 can r trieve unpolymerized IgM 
ubunits, whilst native polymers are allowed to proceed further. 
Not th two-st p IgM biog n sis in which the BiP/PDI-dependent 
~ 2L2 mbly pr c d s th tt mpts to form polym r (depend nt 
on ER IC-53, ERp44 and other mol cuI (An Hi et al., 2007)(Anelli 
and iti 2008). 117 
Given the known pH differences in the ESC organelles, these results may 
be indicative of a physiological mechanism that regulates ERp44 in vivo, 
confirming our working model (Fig. 4.1). Although Arg98 seemed to be 
important for ERp44 to exhibit pH dependence, the plenty of residues 
involved in the interaction between C-tail and domain a and the partial 
inhibition of ERp44 activity suggested hinged-mechanisms whereby ESC 
could regulate ERp44 activity, such as compartment-specific proteins, 
redox-states and calcium concentration. 
4.3 ERp44 substrate binding and release 
In ATP-dependent chaperone Hsp70, the kinetic of binding/release is 
finely regulated by ATP, co-chaperones and nucleotide exchange factors, 
which determine the lifetime of the Hsp70-substrate complex (Mayer and 
Bukau 2005). So far, no regulator or co-chaperone has been reported for 
ERp44. 
Here, we show how different regions of C-tail contribute to regulate the 
kinetic of binding/ release of ERp44 according to a kinetic model in which 
binding activity is inversely correlated to TMR activity. 
Indeed, the removal of the last 9 residues of the C-tail (ERp44M316) is 
sufficient to "unleash" the disulphide-mediated activity but cripples TMR 
activity. Moreover, the partial retention of ERp44~Tail~RDEL with respect 
to ERp44wt~RDEL is highly suggestive of enhanced affinity for ER matrix, 
mirroring the hyper-reactivity of this class of mutants (ERp44~Tail and 
ERp44~P16). According with these data, P16 strand could serve as a lid to 
drastically reduce the accessibility to client proteins of SBS, de facto 
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regulating binding/ release of the protein. Thus, ERp44~P 16 could bind to 
endogenous substrate in non-regulated way resulting in both ineffective 
interactions and impaired traffic along ESC. Although we reported that 
hyper-reactive ERp44~Tail displayed an enhanced chaperone-like activity 
in vitro (see part 3.2), in living cells hyper-reactivity could reduce the 
"dynamic" properties of ERp44 (trafficking and substrate binding-release) 
resulting in less efficient TMR activity. ERp44~P 16 behaviour may 
resemble the canonical ATP-dependent chaperones (Hsp70- Mayer and 
Bukau 2005) in which mutation in ATPase activity that cripples substrate 
release thus resulted in less efficient chaperone activity (Hendershot et al., 
1995) (Wei et al., 1995). 
On the other hand, the removal of His loop results in an enhanced 
efficiency of TMR activity of ERp44. Since His loop is remote to SBS in 
domain a, the removal of this region might affect ERp44 TMR likely 
independently from SBS-accessibility, as reported for ERp44~P 16. Indeed, 
His loop may be involved in the modulation of ERp44, per se and/ or by 
means of interaction with other macromolecular entities. In the crystal 
structure of ERp44, His-loop is invisible, likely due to its intrinsic disorder 
and/ or flexibility. These peculiar features make His-loop a candidate as 
docking site for ligand proteins. Third party proteins might interact with 
this loop, regulating ERp44 activity according to ESC folding demand. 
Third party proteins may inhibit ERp44 activity by means of slowing down 
the substrate-release, trafficking along ESC or a combination of both 
mechanisms. In this case, hypo-reactivity (or faster kinetic cycle of 
binding/ release) is a consequence of missing interaction. 
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Alternatively, His-loop removal could enhance interaction with escort 
protein that meditated physiological ERGIC-Iocalization of non-bound 
ERp44. However, both mechanisms resulted in a partial accumulation of 
ERp44 in downstream compartments. 
Altogether, the enhanced TMR of ERp44~His might reflect a enhanced 
"dynamic" properties of the mutant in terms of higher rate of turnover in 
the ESC and/or faster binding/release cycle. In this scenario, His loop 
may be considered as a "gear lever" by which ESC modulates ERp44 
activity to support ESC folding demand. According with this hypothesis, 
the removal of His-loop might make ERp44 less tuned. 
4.4 Concluding remarks 
Altogether my findings indicate that the flexible C-terminal tail 
dynamically regulates both substrate binding and TMR activity of ERp44 
during protein quality control in the ESC. Moreover, this work supports 
the hypothesis of a role of ESC pH gradient in governing ERp44-TMR 
activity, in which Arg98 seems to be a key residue in mediating pH 
sensitivity of ERp44. 
A deeper knowledge of the structure/function relationship of ERp44 will 
shed light on the protein quality control mechanisms and thus provide 
essential knowledge of ESC processing diseases and in biotechnology, 
improving the production of man-made therapeutic proteins. 
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5. Material and methods 
5.1 Cells and reagents 
BL21 (OE3) and Rosetta-Gami 2 (OE3) were obtained from Novagen. Ni-
NTA resin was purchased from Qiagen. Proteins were purified with AKTA 
purifier and column Superdex 200 10/30 (Amersham Pharmacia Biotech). 
Crystallization kits and plates were purchased from Hampton research. 
HeLa, HEK293 and HepG2 cell lines were obtained from ATCC (Manassas, 
VA, USA), cultured in Oulbecco's modified Eagle's medium supplemented 
with 5% fetal calf serum (FCS), antibiotics and glutamine. FCS, Optimem 
and culture media were purchased from Gibco BRL; Sepharose-conjugated 
protein A and G, ECL reagents were purchased from Amersham-
Pharmacia. OSP was purchased from Pierce. 
Rabbit anti-PO I were kind gifts from Ors. R. M. E. Parkhouse (Pirbright 
Laboratory, Surrey, UK) and I. Braakman (Utrecht, NL); anti-ERp58 were 
generously provided by Dr. S. Bonatti (Naples,IT) , J. Saraste (Bergen, NO), 
E. Neve and R. Petterson (Stockholm, Sweden)(Neve et aI., 2005). Rabbit 
anti-calreticulin was from Stressgen; mouse monoclonal anti-actin (clone 
AC-40) from Sigma Chemical Co; goat anti-mouse horseradish peroxidase 
(HRP); HRP rabbit anti-mouse IgG (H+L) was from OakoCytomation. 
Hoechst, FITC Goat anti-rat IgG (H+L), TRITC Goat anti-rabbit and mouse 
IgG (H+L) from Molecular Probes. Monoclonal Anti-GFP antibodies and 
Anti-His HRP conjugated were purchased from Santa Cruz 
Mouse monoclonal antibodies specific for Myc (9ElO) and HA (12CA5) 
were immobilized by cross-linking to Protein G and Protein A beads 
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respectively (Reddy et aI., 1996). Lipofectin, Lipofectamine and Plus 
reagents were purchase from Invitrogen. Unless otherwise indicated, 
chemicals were purchased from Sigma Chemical Co. 
5.2 Plasmids and vectors 
pET28 vector was obtained from Novagen. The cDNA encoding human 
ERp44 without the signal sequence from pGEX-4T-1-ERp44 (Anelli et aI., 
2002) was amplified by PCR and cloned into pET28 vector at NheI and 
XhoI sites. The vectors for the expression of HA-ERp44 in mammalian 
cells were previously described (Anelli et aI., 2002). HA-ERp44 mutants 
were obtained by PCR (PCR cloning in table 5.1) or by Site-Directed 
Mutagenesis (SDM in table 5.1). The PCR product is re-inserted in 
pcDNA3.1 (-) using the restriction sites XhoI-Acc651. Construct was re-
sequenced before transfection experiments. In order to retain the protein 
in the endoplasmic reticulum, HA-ERp44 mutants have the C-terminal 
RDEL motif left in place. The presence of the tag does not influence the 
function of ERp44 in any of the available assays (Anelli, Ceppi, Bergamelli 
and Sitia, unpublished results). Mouse version of ERp44-GFP-KDEL was a 
kind gift of Prof. E. Snapp (Albert Einstein College of Medicine, NY, USA). 
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PRIMERS PLASM TEMPLATE ERp44 
FW CACCGCTAGCGAAATAACAAGTCTTGA TA CA GAGA A T pET28 pGEXERp44 PeR ERp44wt 
Rv ~CTCGAGTTAATCCCTCAATAGAGTATACCTATAT ckmig 
FW CACCGCTAGCGAAA TAACAAGTCTTGA TACAGAGAA T pET28 pET28 ERp44 SDM ERp44~ ta il 
Rv GCGCCTCGAGTTAAGAATGTAAGTCAAATACGAATTG 
FW GCACCCAGTGAATATAGGTA TTGTCTA TTGAGGGA TTA A CTCG pET28 pET28 ERp44 SDM ERp44 1369c 
Rv CGAGTTAATCCCTCAATAGACAATACCTATATTCACTGGGTGC 
FW CACCGCTAGCGAAA TAACAAGTCTTGA TA CA GAGAAT pET28 pCDNA ERp44 PeR ERp44 
Rv GCGCCTCGAGTTAATCCCTCAATAGAGTATACCTATAT c29s c63s cloning c29s c63s 
FW CACCGCTAGCGACCCCA TTCAAGAAA TTC pET28 pET28 ERp44 PeR ERp44~ l'RX 
Rv GCGCCTCGAGTTAATCCCTCAATAGAGTATACCTATAT cloning 
FW GAGAATACA GGGGTCAGCAGTCAGTGAAAGCATTGGC pCDNA pCDNA ERp44 SDM ERp44 r98q 
Rv GCCAATGCTTTCACTGACTGCTGACCCCTGTATTCTC 
FW CCAGTGAATATAGGTATGCTCTA TTGAGGGA TCG pCDNA pCDNA ERp44 SDM ERp44 1369a 
Rv CGATCCCTCAATAGAGCATACCTATATTCACTGG 
FW CAACTCGAGCGTTACCA TGCA TCCTGCC pCDNA pCDNA ERp44 PeR ERp44.';tail 
Rv CACGGTACCTTAAAGCTCA TCTCGTTCTCTGTGCAGTTTTCCAGAA cloning 
FW GAAAACTGCACAGAGAATAACATCATGGACCTGACCC pCDNA pCDNA ERp44 SDM ERp44c\ lail 
Rv GGGTCAGGTCCA TGA TGTTA TTCTCTGTGCAGTTTTC ~RDa 
FW CAACTCGAGCGTTACCA TGCA TCCTGCC pCDNA pCDNA ERp44 PeR ERp44~p 1 6 
Rv GCGCGGTACCTTAAAGCTCATCTCGACTGGGTGCTAGTTTCTGGAAG clonng 
FWI ~GCGGATCCGGTAGTCCACCTGAGAGCTCCTTC pCDNA pCDNA ERp44 cui ERp44 his 
Rv1 GCGCGGATCCAGATCCAGAATGTAAGTCAAATACGAA and 
FW CAACTCGAGCGTTACCA TGCA TCCTGCC pasle 
Rv GCGCGCGGTACCTTAAAGCTCATCTCGATCCCTC 
FW CACCCAGTGAATATAGGTATTGTCTATTGAGGGATCGAGATG pCDNA pCDNA ERp44 SDM ERp44 1369c 
Rv CATCTCGATCCCTCAATAGACAATACCTATATTCACTGGGTG 
FW CCCAGCGAGTATAGGTA TTGTTTA TTGAGGGA TCGAG pEGFPN1 pEGFPNl SDM ERp441369c 
Rv CTCGA TCCCTCAATAAACAATACCTA TACTCGCTGGG ERp44 
Table 5.1. ERp44 cloning primers. 
5.3 Preliminary bioinformatic analysis 
The bioinformatic analysis was carried on to identify physic-chemical 
characters, secondary structure and disordered regions. Several tools from 
the World Wide Web were used to analyze protein sequence of human 
ERp44 . 
The sequence was analysed through the foHowing tools: 
• Prot. Param., a tool that allows the computation of vanous 
physical and chemical parameters for a gIven protein stored in 
Swiss-Prot or TrEMBL databases or for a user entered sequence. 
The computed parameters include the molecular weight, theoretical 
isoeletric point, ammo acid composition, atomic composition, 
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extinction coefficient, estimated half-life, instability index. 
wVlw.expasy.org. 
• RONN (Regional Order Neural Network), a computational tool 
for prediction of disordered/unstructured regions within a protein 
sequence. http://www.strubi.ox.ac.uk/RONN (Yang et al. 2005). 
• CDD (Conserved Domain Database), protein annotation 
resource that consists of a collection of well-annotated multiple 
sequence alignment models for ancient domains and full-length 
proteins. COD content includes NCBI-curated domains, which use 
3D-structure information to explicitly define domain boundaries and 
provide insights into sequence/structure/function relationships, as 
well as domain models imported from a number of external source 
databases (Pfam, SMART, COG, PRK, TIGRFAM). 
http://www.ncbLnlm.nih.gov I Structure Icdd/cdd.shtml (Marchler-
Bauer et al., 2005). 
5.4 Protein expression and purification 
The pET28-ERp44 and mutants were expressed in BL21 (DE3) or Rosetta-
Gami 2(DE3) competent cells for protein production. Cells were grown at 
37°C in LB medium containing 50 mg/ml kanamycin. Protein expression 
was induced at a culture 00600 of 0.6/0.8 by addition of 0.1 mM IPTG. 
Cells were harvested after 18 h at 20°C by centrifugation and re-
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suspended in 1/ 10th volume of a ice cold buffer containing PBS buffer + 1 
mg/mllysozyme, 20 mg/ml ribonuclease A, 2 mg/ml deoxyribonuclease I, 
Complete EOTA-free protease inhibitor cocktail and 2p-mercaptoethanol 
where indicated. Cells were disrupted by sonication at 4°C using a 
Bandelin sonicator. Cellular debris was removed by centrifugation at 25 
OOOg for 30 min at 4°C. 
5.4.1 Affinity purification 
For a good balance of protein recovery versus specificity, 500 pI of Ni-NTA 
resin were employed for every 1 L of starting culture volume. Ni-NTA resin 
was added to the clear supernatant and incubated for 1 h with gentle 
shaking at 4°C and then loaded onto a polypropylene column. Unbound 
proteins were removed by washing the resin with 100 column volumes of 
washing buffer (PBS buffer + 15 mM imidazole). Bound proteins were 
eluted with the same buffer containing 0.5 M imidazole. The elution was 
repeated four times to maximize the recovery without diluting excessively 
the protein concentration. 
5.4.2 Size exclusion chromatography 
The affinity-purified ERp44 was injected onto a Superdex 200 10/30 size 
exclusion chromatography column equilibrated with 20 mM HEPES pH 
7.5, 150 mM NaCI, 1mM OTT where necessary. Purified ERp44 was 
digested overnight at room temperature with thrombin at a ratio 1: 1000 
(w:w) after dialysis against a buffer containing 20 mM Tris-Cl pH 8.3, 150 
mM NaCI, 2.5 mM EOTA. The digested protein was loaded onto a 
Superdex 200 chromatography column as described above to remove the 
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protease and the cleaved His tag. All mutated proteins were expressed and 
purified using the same protocol for the wild type ERp44 (except where 
indicated) . 
5.4.3 Selenomethionyl ERp44 
Single-wavelength anomalous dispersion (SAD) is a technique used in X-
ray crystallography that facilitates the determination of the structure 
of proteins or other biological macromolecules by allowing the solution of 
the phase problem. The most popular method of incorporating anomalous 
scattering atoms into proteins is to express the protein in a media rich in 
se1enomethionine, which contains selenium atoms. The selenomethionyl 
ERp44 was prepared using the method of methionine-biosynthesis 
pathway inhibition (Doublie 1997) (Liu et al., 2005) and purified using the 
same protocol for the native ERp44 adding 5mM DTT in every purification 
step. The molecular weight of the recombinant ERp44 and the SeMet 
incorporation were determined by MALDI-TOF mass spectrometry. 
5.4.4 Dynamic light scattering 
.Qynamic 1ight Scattering (DLS) is used to determine the size distribution 
profile of small particles in solution. In this instrument the sample is 
analysed based on the diffraction pattern of a laser light. 
Protein solutions were centrifuged at 20000g for 30 min at 4°C to remove 
precipitates or dust particles. DLS measurements were performed at 4°C, 
25°C and 37°C on a DynaPro MS/X instrument with temperature control 
(Protein Solutions). Laser intensity, time of acquisition and number of 
measurements were optimized to minimize the residual to the fitted 
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scattering curves. The ERp44 concentration used was 0.1 mg/ml. Data 
collection and deconvolution was performed using the DYNAMICSv.6 
software. The degree of polydispersity (the lower the better) obtained from 
DLS measures were related to the probability to obtain crystals. 
5.5 Crystallization and data collection 
The crystallization process consists of two major events, nucleation and 
crystal growth. Nucleation is the step where the solute molecules 
dispersed in the solvent start to gather into clusters that can dissolve or 
become stable nuclei. It is at the stage of nucleation that the atoms 
arrange in a defined and periodic manner that defines the crystal 
structure. The crystal growth is the subsequent growth of the nuclei that 
succeed in achieving the critical cluster size. Nucleation and growth 
continue to occur simultaneously while the supersaturation exists. 
Supersaturation is a thermodynamically unstable state in which the 
solution contains more molecules dissolved than it would contain under 
the equilibrium. The supersaturation state can be further divided into 
three different zones: the metastable, the nucleation and the precipitation 
zone. Only in the nucleation zone the protein crystals nucleate and grow, 
while in the first one the solution may not nucleate for a long time, even if 
preformed crystals growth would be sustained, and in the precipitation 
zone proteins do not nucleate but precipitate out of solution. To 
supersaturate a protein solution there are two main possibilities: 
increasing the protein concentration, or adding a second reagent that 
reduces the sample solubility (Fig 5.1). 
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ERp44 was crystallized using mainly the hanging drop vapour-diffusion 
technique. This is the most used technique for the crystallization of 
macromolecules in which a drop composed of a mixture of sample and 
reagent is placed in vapor equilibration with a liquid reservoir of reagent. 
The drop contains a lower concentration of reagent than the reservoir, so 
water vapor slowly leaves the drop to achieve equilibrium, eventually 
ending up in the reservoir. As water leaves the drop, the sample 
undergoes an increase in relative supersaturation. Both the sample and 
reagent increase in concentration as water leaves the drop for the 
reservoir. Equilibration is reached when the reagent concentration in the 
drop is approximately the same as that in the reservoir. 
Equal volumes of a protein solution at 10 mg/ ml in 20 mM HEPES buffer 
pH 7.5, 150 mM NaCl and 1 mM OTT and precipitant solution (2 /-11 each) 
were mixed and placed on a cover slip over 500 ml of reservoir solution 
and incubated at 20°C. The crystals were dehydrated for -24 h, then were 
transferred to artificial mother liquor containing 25% glycerol for 
cryoprotection and finally were immediately flash-cooled in a nitrogen 
stream at 100 K. Data collection at the wavelength of 0.97372A at lOOK 
was performed at the beam line 1029 of the European Synchrotron 
Radiation Facility Grenoble (France). 
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Figure 5.1 Solubility curve of a protein 
5.6 Biochemistry and cell biology analysis 
5 .6 .1 Pull-down assay 
Pull-down assay of ERp44 proteins. Glutathiol Sepharose 4 fas t-flow 
beads (GE H althcare) w r incuba t d at 25°C and pH 7 .5 for 1 h with 
10-6 M GST-Ero1 a and va rious ERp44 proteins, a s indicated , and then 
anal s d by SDS-pag und r r ducing conditions after being washed five 
tim s. 
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5.6.2 Chaperone-like activity 
Chaperone activity was determined as described previously (Song and 
Wang 1995).Briefly, in all experiments, 0.2 M sodium phosphate, pH 7.5, 
was employed and the refolding buffer contained 5 mM DTT and 50 mM 
sodium thiosulfate. Denaturation of rhodanese was carried out by 
incubation of 90 IlM enzyme in 6 M Gdn-HCI with 10 mM dithiothreitol for 
at least 30 min at room temperature for complete denaturation. Refolding 
was initiated by dilution of the denatured enzyme into the refolding buffer 
at 20°C. The final concentration of Gdn-HCI was roughly 0.3 M, a 
concentration that has no observable effect on the refolding of rhodanese. 
The aggregation of rhodanese was continuously monitored at 350 nm by 
measuring the light scattering obtained at 90° in a Hitachi F -4010 
spectrofluorometer. ERp44 and PDI were added to rhodanese at molar 
ratio of 8. 
5.6.3 VVestern blots 
HeLa, HEK293 and HepG2 cell lines were transfected and analysed as 
described previously (AneUi et aI., 2002, 2003). Anti-HA antibodies 
(12CA5) used 1:1000 dilutions. Anti-Myc antibodies (9E10) 1:1000 
dilution. Anti-GFP (1:500 dilution). Anti-His HRP conjugated (1:1000). 
5.6.4 Chemical cross linking 
Cells were washed and incubated for 30 min at 4°C with ImM DSP on a 
rocking platform. The reaction was quenched by rinsing the cells once 
with 20mM Tris-HCI pH 7.4, followed by two incubations for 15 min at 
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room temperature with the same buffer. Cells were then lysed In RIPA 
buffer+ 10mM NEM + complete™. 
5.6.5 Immunoprecipitation 
For isolation of ERp44/Erola complexes and ERp44/Jl~CH1), aliquots of 
the cell lysates (corresponding to 106 or 3* 106 cells) were IPed with anti-
HA or anti-Myc, immobilized on Protein A beads (Reddy & Corley 1998) 
washed three times with STN buffer (20 mM Tris-CI pH 7.7, 150 mM NaCI 
, 0.25% NP-40). 
For isolation of ERp44/ERGIC-53 complexes, cells were washed with PBS 
+ 2 mM CaCh and then cross-linked with DSP. 
Cell lysates were IP with anti HA-antibodies immobilized on Protein A 
beads, and then washed three times with STN buffer (20 mM Tris pH 7.7, 
150 mM NaCI, 0.25% NP-40) 
5.6.6 Stability assay 
Two days after transfection, HeLa cells were treated with cycloheximide 
0.5 mM (CHX) for 1, 2 or 4 h as indicated. After treatment, cells were 
harvested and lysated in RIPA buffer (20 mM Tris pH 7.7, 150 mM NaCl, 
0.1 % SDS) + 10 mM NEM+ CompleteTM • 
For detergent solubility assay, HeLa cells were lysed in NP-40 buffer (20 
mM Tris-CI pH 7.4, 150 mM NaCI, 1% NP-40) or SDS buffer (20 mM Tris 
pH 7.4, 150 mM NaCI, 2% SDS) at 48 h after transfection. NP-40 soluble 
and insoluble fractions were separated by centrifugation, and aliquots 
corresponding to the same number of cells resolved by SDS-page. 
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5.6.7 Secretion assay 
For secretion assays, two days after transfection, cells were washed 3 
times and then cultured in OPTIMEM, in presence of 50 mM NH4CI where 
indicated. After 4 to 16 hours, 10 mM NEM was added to block disulphide 
interchange, supernatants harvested and cells lysed in RIPA buffer (20 
mM Tris-CI pH 7.7, 150 mM NaCI, 0.1% SDS) + 10 mM NEM+ Complete™. 
(Anelli et al., 2002). Aliquots of supernatants (corresponding to 2*106 cells) 
were precipitated with Sepharose-bound Concanavalin A to concentrate 
glycoproteins or IP with Sepharose-bound anti-HA antibodies or 
precipitated with 20% of TCA. Lysates of 105 cells and supernatants were 
resolved under reducing or non-reducing conditions as indicated 
Western Blots images were acquired with the Chemidoc-it Imaging System 
(UVP). Densitometric analysis was performed using Image Quant 5.2. 
ERp44-meditated Ero1a retention was determined as the ratio between 
the signal revealed with anti-Myc antibodies in the intracellular fractions 
and the signal of the supernatant. 
5.6.8 Immunofluorescence 
HeLa cells were flxed with Methanol 100% for 10 seconds, and then 
stained as described in (Anelli et al., 2007) with HA-antibodies (rat 1: 1000 
dilution), Calreticulin (rabbit 1 :500 dilution), ERGIC-53 or GM 130 (mouse 
1 :500 dilution). 
HeLa cells were then analyzed on an Olympus inverted fluorescence 
microscope (model IX70) with DeltaVision RT Deconvolution System 
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(Alembic, HSR, Milano). After deconvolution, images were processed with 
Adobe Photoshop 7.0 (Adobe Systems Inc.). 
5.7 Molecular dynamics simulation 
The X-ray structure of ERp44 was used to prepare the starting 
configuration for the Molecular Dynamics (MD) simulations of the wild 
type protein. The ~1316-ERp44 structure was generated by deleting the 
coordinates of the Glu365-Arg372 segment. The missing loop in the a 
domain (Phe50-Glu53) was modelled with the ModLoop server (Fiser et al. 
2000). The resulting structure was immersed in a cubic box (- 97 x 97 x 
97 A3) of - 29,000 TIP3P water molecules and 13 Na+ counterions. All the 
simulations and the subsequent analysis were performed with GROMACS 
3.3.3., using the ff-amber99sb porting (Sorin & Pande 2005) of the 
AMBER parm99SB parameter set (Hornak et al. 2006). 
Periodic boundary conditions were imposed. The equations of motion were 
integrated using the leap-frog method with a 1-fs timestep. The Berendsen 
algorithm was employed for temperature (T=300 K) and pressure (p= 1 bar) 
regulation, with coupling constants of 0.1 ps. Bonds to hydrogen atoms 
were frozen with the LiNeS method for the protein and the ligand, while 
SETILE (was used for water molecules. The Particle Mesh Method was 
used to calculate electrostatic interactions, with a 11-A cutoff for the 
direct space sums, a 1.0-A FIT grid spacing and a 6-order interpolation 
polynomial for the reciprocal space sums. For van der Waals interactions, 
a switching function was used with a double 9-10 A cutoff. Long-range 
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corrections to the dispersion energy were also included (Shirts et aI., 
2007). 
The system was first minimized with 2000 steps of steepest descent. 
Harmonic positional restraints (with a force constant of - 12 kcal/mol/ k~) 
were then imposed onto the protein heavy atoms and gradually turned off 
in 400 ps, while the temperature was increased from 200 to 300 K. The 
system was then simulated for 5 ns. To assess the reproducibility of the 
results, two trajectories were generated for the wild type protein following 
the same protocol. The L\(316 protein simulation was prolonged to 10 ns. 
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avermi guidato in tutti questi anni con consigli e pacche sulle spalle: 
credo che senza Stefano non sarei qua a scrivere questi 
ringraziamenti. 
La mia riconoscenza va a Luca Pellegrini, external supervisor, per i 
pochi ma ottimi incontri di questi anni: sempre forieri di consigli e 
ottime idee. 
Scientificamente credo di dover ringraziare CC. Wang (Pechino-Cina) e 
Kenji Inaba (Fukuoka-Giappone) per le fruttuose collaborazioni!!!!! 
Un grandissimo GRAZIE ai DiBiters che in questi an no hanno condiviso 
momenti di lavoro e "Iudici". Specialmente i membri del gruppo Casari-
Rampoldi,Musco, Valtorta e Biffo su tutti!!!!!! 
A proposito di DiBiters, un immenso GRAZIE va a miei compagni di 
PhD Eugenio, Tanguy, Barbara e Patrizia! 
Last but not least, Viviana! Grazie per tutto! 
Un piccolo spazio 10 lascio anche al MITICO autobus 925 per i 
meravigliosi viaggi!La mensa HSR ("buonissima"), i blackout elettrici 
(soprattutto quando si lavorava sotto cappa sterile), i freezer -80 
(quando "saltano" durante il week end), la stanza di cristallizzazione 
( .. si muore di freddoooooo li dentro), la macchinetta del caffe ( 
compagna sempre presente ... nei momenti belli e in quelli brutti), i 
DiBiT retreats + annual PhD students workshops (con relativa SPA e 
dinner party), i "flames" sulla mailing list del DiBiT, i "Iitigi" con i 
colleghi per decidere se accedere 0 meno I'aria condizionata, il 
GRANDISSIMO parcheggio del DiMeR (il mio meccanico e gommista 
ringrazia calorosamente), gli "algoritmi decisionali" per stilare la lista 
dei lab. meetings, i "think tanks" fra PhD students per migliorare le 
cose (aime con pochissimi risultati pratici), iI "micoplasma" che 
contamina le cellule in coltura(ma alia fine si e capito se fa male alle 
cellule?), gli anticorpi che non funzionano (maledetti HA e JAD1), le 
riunioni che iniziavano alle 19, i potentissimi "guardiani" (0 addetti alle 
chiavi), I' Angelo, gli stressanti reports + PhD seminars e tanto altro 
ancora ..... 
sarete SEMPRE NEL MIO CUORE 
Vorrei ora concludere augurando in bocca al lupo: 
• Ai PhD students (PhD tesi): cercate di divertirvi con iI vostro 
progetto di dottorato (che alia fine durera quasi 5 anni). E' 
un'occasione unica! !Ascoltate attentamente i consigli dei vostri 
supervisors, ma non lasciate che siano loro a fare la vostra 
ricerca: il progetto e vostro!!!!!!! Per quasi 5 anni mi sono 
divertito come un matto a pensare e fare esperimenti per capire 
come funzionava ERp44 (weekends e vacanze estive-invernali 
spesso "rimandate" in favore della sCienza ... ). Vorrei continuare a 
lavorarci su ancora per tanto tempo!!!!!!!!!!!!!!!!! 
• Ai PhD students (social life): non vi chiudete in lab. a fare 
esperimenti. Andate ai seminari e interagite con piu persone 
possibili!!!! Conoscere persone da tutto iI mondo arricchisce e 
permette di confrontarsi e fare una ricerca migliore. E poi ci si 
diverte sempre la sera a bere una birra con i proprio colleghi. In 
questi anni ho incontrato molte persone al Dibit: bizzarre, 
intelligenti, particolari, strane, simpatiche, mediocri, false ma 
tutte mi hanno lasciato un ricordo!! 
• A colui\e che seguira il progetto su ERp44:ora tocca ate. 
• Alia MERITOCRAZIA nell' universita italiana (per quello che 
f ) . I' I . f 1111 conosco, 0 course ....... coragglo c e a posslamo are ... . 
Tralascio i ringraziamenti riguardanti argomenti non lavorativi: la tesi e 
gia stata dedicata!! I!!!! I Posso aggiungere solo i miei gattini persiani 
(Izzi e Pandorino).Comunque ci sono state persone che, nonostante 
tutto, ricordero per sempre in quanto hanno segnato indelebilmente 
questi anni, anche piu del/a mia cara ERp44. Non credo ne siano 
consapevolil 
~o 27/07/2010 
